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ABSTRACT 
Parkinson disease (PO) is a progressive neurodegenerati ve disorder characterized 
by the loss of dopaminergic neurons in the substantia nigra pars compacta. As a result, 
affected individuals have impaired motor function typically coupled with several non-
motor symptoms that ari se from extra-nigra ) damage. Mutations in the human a-
synuc/ein (SNCA ) gene have been linked to heritable autosomal dominant PO and 
duplications o f its gene locus result in a more severe early onset form o f the di sease. 
Post-mortem analysis of patient brains revea ls increased levels of ox idati ve stress 
biomarkers in individuals with PD. I investigated the potentia l therapeutic e ffects of a 
diet high in antioxidants both in a Drosophila me/anogaster model of PO and on a-
.synuc/ein- induced developmental defects of the neuron-rich eye. Longev ity assays, 
climbing tria ls, and biometric analyses were performed to test the effects of blueberry 
extract (BBE) on several a-synuc/ein-induced phenotypes. My results suggest that a diet 
supplemented with BBE rescues a-sy nuc/ein-induced degeneration in D. me/anogas/er. 
Both reduced lifespan and disruption to the extem al morphology of the eye induced by a-
synuc/ein were improved in individuals fed a die t supplemented w ith BB E. These 
findings demonstrate that BBE counteracts PD-like phenotypes in an animal model o f 
prote in tox ic ity and suggest that dietary antiox idants may a lleviate some of the cellular 
stress caused by excess a-synuc/ein. Diets rich in sources of antiox idants, li ke 
blueberries, could become a useful tool in treating PO and other similar 
neurodegenerative d isorders if this re lationship is conserved in humans. 
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INTRODUCTION 
Parkinson disease: frequency and symptoms 
Parkinson disease (PO) is the second most common progressive 
neurodegenerative di sorder surpassed in frequency by Alzheimer disease a lone 
(Weintraub e/ a/. , 2008; de Moura eta/. , 20 10). Incidence and prevalence rates of 
affected individuals increase with age from 0.3% of the genera l population to I - 2% of 
individuals over the age of 65 years, with rates reaching as high as 4% in the 80-plus age 
category (de Rijk et a/. , 2000; Van Den Eeden et a/., 2003; McNaught and Olanow, 
2006). In Canada, PO affects close to I 00,000 individuals and is the 13111 leading cause of 
death, accounting for over 13,000 deaths in the years 2000 - 2007 (Tables I and 2). Wi th 
more people survi ving well into old age, the burden to both families and society caused 
by late-onset disorders such as PO is likely to increase in the future. 
First described in 18 17 by James Parkinson, PO is a slowly progressive 
neurodegenerative disorder that is characterized clinically by bradykinesia (i.e. slowed 
movements), resting tremor, muscular rigidi ty, and gait abnormalities (Parkinson, 18 17). 
There are also several non-motor symptoms that are exhibi ted by PO patients, including 
depression, dementia, obsessional behaviour, and olfactory dysfunction (Weintraub et a/., 
2008). The ha llmark pathological event in PO is the loss of dopaminergic (DA), or 
dopamine producing, neurons in the substantia nigra pars compacta (SNc), however, 
1 
Table I - Annual deaths from Parkinson disease for both sexes 1 and all age groups 
in Canada for the years 2000 - 20072 
Cause of death -
Year Parkinson disease Secondary parkinsonism 
2000 1471 
2001 1600 
2002 165 1 
2003 1662 
2004 1642 
2005 1866 
2006 1664 
2007 1869 
I Missing data on sex of the deceased were imputed based on death registration number. 
'2 Source: Statistics Canada, Canadian Vita l Statistics, Death Database 
9 
9 
13 
17 
15 
24 
22 
2 1 
3 World Health Organization (WHO), Inte rnational Statistica l C lassification of Diseases and Related ll ea lth 
Problems. Tenth Revision ( IC D-10) 
4 The cause of death tabulated is the underly ing cause of death. This is de lined as (a) the disease or injury 
which initiated the train o f events leading directly to death, or (b) the circumstances o r the accident or 
violence wh ich produced the fata l injury. T his underly ing cause is selected from a number of conditions 
li sted on the death registration form. 
5 Counts in thi s table exclude deaths of non- residents of Canada. 
6 To reduce the s ize o r the table, only causes of death w ith a frequency o r one or more in Canada are 
reported. 
Modified from : Stati stics Canada. Table 102-0526- Deaths, by cause, Chapter VI : Diseases o f the nervous 
system (GOO to G99), age group and sex, Canada, annua l (number) (table), CA NSIM (database), 
htt ): 1111 w.statcut. l!c.~:a (accessed: January 7, '20 II). 
2 
Table 2- Annual ranking of Parkinson disease among the leading causes of death I-J 
4 II . 5 6 fi h 0 7 X for both sexes and a age groups 111 Canada · or t e years 2000 - 20 7 · 
Year 
2000 
2001 
2002 
2003 
2004 
2005 
2006 
2007 
Rank of leading causes of 
death9 
13 
13 
13 
13 
13 
13 
14 
13 
Number of deaths 
1480 
1609 
1664 
1679 
165 7 
1890 
1686 
1890 
I The cause of death tabulated is the underly ing cause of death . This is de lined as (a) the disease or inj ury 
which initiated the tra in of events leading di rectly to death , or (b) the ci rcumstances of the accident or 
violence which produced the fatal injury . T he underlying cause is selected from the condit ions listed on 
the medica l certificate of cause of death. 
2 World Hea lth Organization (WHO), International Statistica l C lassification of Diseases and Re lated Health 
Problems, I Oth Revision ( lC D-I 0). 
3 T he list for ranking leading causes of death that is used in this table is based on the list that was developed 
and that is been used by the National Cente r for Health Statistics of the United States in their ann ual 
report on lead ing causes of death. 
4 Missing data on sex of the deceased were imputed based on the death registration number. 
5 Counts in this table exclude deaths of non-residents of Canada. 
6 The category 'Canada' includes deaths with unknown province or territory of residence in Canada. 
7 Death refe rs to the permanent disappearance of all evidence of life at any time after a li ve birth has taken 
place. Sti llbirths are excluded. 
8 Sources: Statistics Canada, Canadian Vital Stati st ics, Death Database and population estimates 
9 The ranking of the leading causes of dea th is based on the number of deaths. 
Modified from: Stati stics Canada. Table 102-0563- Leading causes of death, total population, by sex, 
Canada, provinces and territories, annual (table), CANS I M (database), htt [l : 1!1\" 1\ .s t atcan.~.c;~ (accessed 
January 7, 20 II) 
3 
considerable extranigral damage a lso occurs (Je llinger, 199 1; Braak and Braak, 2000). 
Addi tionally, prote inaceous intraneuronal inclusions known as Lewy bodies (LB) and 
Lewy neurites (LN) are found in the perikarya (cell body) and processes, respectively, of 
surviving neurons in PO patient brains (Lewy, 19 12; Forno, 1996). Secondary forms of 
parkinsonism with similar symptoms can be caused by medications, tox ins, infections to 
the central nervous system, and vascular/metabolic disorders (Weintraub eta/., 2008). 
The multi-symptom etiology of PO, caused by irreparable damage to neurons, highlights 
the importance of cell survival in neurodegenerati ve disorders. 
Parkinson disease: genetics and a-synuclein 
The occurrence of PO was ini tially believed to be enti re ly sporadic in nature. 
Though the majority o f cases seem to be idiopathic, I 0 - 30% of affected subjects 
reported a positi ve family history in recent epidemiological studies (Shulman et a/. , 
20 I I). Eighteen Parkinson-associated (PA RK) loci have been identi ti ed to-date through a 
combination of linkage, segregation, and sequence ana lyses; though several require 
validation by independent studies (Table 3). In addi tion to the eighteen PARK loci, the 
Gaucher's locus has been linked to PD. This locus contains the g/ucocerebrosidase 
( GBA) gene whose product catalyzes the breakdown of glucocerebroside to glucose and 
ceramide. Loss of function mutations in GBA were fi rst associated with Gaucher's 
disease, an autosomal recessive lysosomal storage di sorder. Despite not being classi tied 
4 
Table 3 -Genetic loci linked to Parkinson disease susceptibility in humans 
Locus Chromosome Gene Inheritance Clinical 
phenotype 
PARK/14 4q21 S NCA AD EOPD 
PARK2 6q25.2-q27 Parkin AR Juvenile and 
EOPD 
PARK3 2pl3 Unknown AD LOPD 
PARKS 4pl4 UCH-LI AD LOPD 
PARK6 lp35-p36 PINK/ AR EOPD 
PARK7 lp36 DJ-1 AR EOPD 
PARK8 12ql 2 LRRK2 AD LOPD 
PARK9 lp36 ATP/3A2 AR Kufor-Rakeb 
syndrome 
PARK/0 lp32 Unknown Unknown Unclear 
PARK/I 2q36-q37 GIGYF2 AD LOPD 
PARK/2 Xq Unknown X-linked Unclear 
PARK/3 2p l3 HTRA2 AD Unclear 
PARK/4 22q 13. 1 PLA2G6 AR Parkinsonism 
with additional 
features 
PARK/5 22q 12-q 13 FBX07 AR EOPD 
PARK/6 lq32 Unknown Susceptibility LOPD 
locus 
PARK/7 4p16 GAK Susceptibility LOPD 
locus 
PARK/8 6p21.3 HLA-DRA Susceptibi li ty LOPD 
locus 
Gaucher's locus lq2 1 GBA N/A N/A 
AD: autosomal dominant; AR: autosomal recessive; EOPD: early-onse t Parkinson disease; LOPD: late-
onset Parkinson disease; N/A: information not available 
Bold text indicates monogenic form s that a re we ll validated 
Table adapted li·om (Kumar el a/., 20 I I) 
5 
as a PARK locus, Gaucher's disease patients can develop parkinsonian features and 
mutations in GBA are frequently found in clinical populations with sporadic PO 
(Neudorfer et a/. , 1996; Tayebi et a/. , 200 I; C lark et a/. , 2007; Gan-Or et a/., 2008). 
Familial cases occur less frequently than idiopathic PO, however the numerous genetic 
linkages and increased disease susceptibility caused by gene mutations makes the genetic 
study o f PO worthwhile. 
Less than two decades have passed since the discovery of the first gene associated 
with PD. Studies of an inherited form o f autosomal dominant PO (ADPD) in an Ita lian 
kindred and three unrelated famili es of Greek origin identified SNCA (PARK 1/4), herein 
refetTed to as a.-synuclein (a.-syn), as the first gene linked to PO (Polymeropoulos et a/. , 
1997). Both point mutations and multiplications of its gene locus result in ADPD, the 
latter causing a more severe early-onset fonn of the disease (Kruger et a/. , 1998; 
Singleton et a/. , 2003; Chartier-Harlin et a/. , 2004; Farrer et a/. , 2004; Zarranz et a/. , 
2004 ). One of the major protein components of LBs and LNs in the SNc of patients with 
idiopathic PO was discovered to be a -Syn (Spillantini et a/. , 1997). This di scovery 
implicated a.-syn in sporadic disease cases and suggested that two distinct mechanisms 
may exist for a.-syn-induced PO pathology. Although famili al cases associated with this 
gene are re latively rare, it is evident that a.-sy n plays a cri tica l role in PO etiology. 
6 
a-synuclein structure, function, and toxicity in Parkinson disease 
Human a-Syn, along with ~- and y-Syn, belongs to the synucle in family of 
proteins that are abundantly expressed in the brain. The a-syn gene consists of a I 14 kbp 
sequence and encodes a 140 aa peripheral membrane protein that localizes to the pre-
synaptic region of neurons (Maroteaux et a/. , 1988). The protein structure of a -Syn 
contains three distinct regions: i) an amino terminus with apolipoprotein lipid-binding 
motifs, ii ) a central hydrophobic region known as the non-A~ component (NAC) that is 
involved in aggregate formation, and iii ) a highly negati ve and often unstructured 
carboxyl terminus (Figure I). Although an exact physio logical function is unknown, 
mice overexpressing a-syn have impaired neurotransmitter release and recycling (Nemani 
et a/. , 20 I 0). Additionally, increased amounts o f a -Syn impa ired dopamine release in 
neurons isolated from mice that typically express a-syn at low levels (Larsen et a/., 2006). 
Taken together, these results suggest that a-Syn acts at the pre-synapse and controls 
neurotransmitter release. 
The toxicity of a -Syn appears to depend on its conformation and solubili ty in 
cell s. Conway et a/. discovered that both wild type (WT) and disease-re lated mutants of 
a-Synform amyloid-like fibrils after prolonged incubation in solution (Conway eta/., 
2000). Aggregation consists of a series of events beginning with the nati vely un folded 
protein and culminating in mature fibril form ation and is be lieved to be the main 
pathogenic mechanism o f a-Syn (Stefan is, 20 12). In support of this view, WT a-Syn 
with a disrupted NAC domai n were neither found to aggregate nor affect the survival of 
Drosophila DA neurons (Periquet et a/. , 2007). It was a lso discovered that Heat Shock 
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Figure I -Schematic of a-Synuclein protein structure. ApiBM : apolipoprote in lipid-
binding motif; NAC: non-A~ component; AT: acidic tail ; N : amino terminus: C: carboxyl 
terminus. Arrows indicate location ofmutations linked to ADPD. 
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Protein 70 (HSP70), a molecular chaperone that prevents prote in misfolding and 
aggregation, protects DA neurons against a-Syn toxicity and reduces aggregation (A uluck 
eta/. , 2002; Klucken eta/., 2004). Conversely, other studies question the proposed 
protective effects of HSP70 (Shimshek et a/., 20 I 0). Some speculate that the final 
aggregated form of a-Syn is less toxic than premature, soluble oligomers. Protein 
accumulation is wide ly implicated in both idiopathic and familial PO pathogenesis and 
the formation of LBs and LNs is believed to confer protection during neurodegeneration 
(McNaught and Olanow, 2006). Additionally, preventing phosphorylation of a-Syn at 
Ser 129 promotes aggregate formation and reduces toxicity (Chen and Feany, 2005). 
Understanding the pathogenic mechanisms involved with a-Syn toxicity could unvei l 
severa l new therapeutic targets in the treatment of PD. 
Oxidative stress and its consequences 
Highly reactive endogenous atoms or molecules can cause cellular damage. 
Reacti ve oxygen species (ROS) are chemically reactive cellular by-products that contain 
oxygen. Due to their unpaired electrons, ROS are highly electrophilic and attack nitrogen 
containing compounds (e.g. nucle ic acids, proteins, and amino acids) and carbon-carbon 
double bonds, like those found in polyunsaturated fatty acids and phospholipids in the 
lipid bilayer of the cel l membrane, as they are sites of increased electron density. Though 
they are potentially harmful , ROS mediate cell growth, migration, and di fferentiation 
when present in low to moderate amounts (Palmer and Paulson, 1997; Valko eta/., 2007). 
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Cells are equipped with endogenous antioxidant enzyme defenses that keep ROS levels in 
check. However, excess generation of ROS can exhaust this system causing the cell to 
experience oxidative stress whereupon de leterious effects occur and pathways leading to 
apoptosis and senescence are triggered (Chandra et a/. , 2000). The majority of 
endogenous ROS seem to be generated from four sources: i) normal aerobic respiration, 
which sequentially reduces molecular oxygen and re leases ROS by-products; ii) 
phagocytic cells that fend off bacteria and viruses with a mixture of nitric oxide (NO), 
superoxide (0 2• -), hydrogen peroxide (H20 2), and hypochlorite (OCr ); iii) peroxisomes, 
organe lles that produce H20 2 as a by-product during the degradation o f fa tty acids; and 
iv) cytochrome p450 enzymes in animals that protect against ingested tox ic plant 
chemicals but produce DNA-damaging ROS during the process (Ames e/ a/. , 1993). 
External stimuli can contribute to the amount o f ROS in a cell as pollution, radiation, and 
xenobiotics can induce ROS-mediated damage (Ziech el a/. , 20 I 0; Gros icka-Maciag, 
20 II ). Oxidative stress is a complex process and can be triggered from many di fferent 
angles. 
Oxidative stress has long been implicated in ageing and chronic pathologies. 
Harman first addressed the issue when he proposed the Free Radical/Oxidative Stress 
T heory of Ageing in the 1950's (Harman, 1956). T his theory states that ageing is a 
consequence of the accumulation of free radical- induced damage to cellular 
macromolecules that occurs over an organism's lifespan. Since that time, evidence o f 
ox idative stress has been found in many common human di seases including hypertension, 
cancer, and neurodegenerative disorders (Calabrese el a/. , 2005; Sonora e/ a/. , 2006; 
Culmsee and Landshamer, 2006; Manrique el a/. , 2009; Schapira and Jenner, 20 I I). 
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Antioxidant therapies may have a future in modern medicine given the ubiquity of ROS 
and oxidative stress in disease etiology. 
Evidence of oxidative stress in Parkinson disease 
Whether it is a causative factor or the result of other cellular insults, oxidative 
stress is consistently associated with PO pathogenesis. Both expression and activity of 
mitochondrial complex I, a member of the electron transport chain, were found to be 
reduced in PO patient brains (Schapira et a/. , 1989). Other oxidative stress biomarkers 
such as decreased levels of reduced glutathione, as well as increased levels of Mn 
superoxide dismutase (SOD2) and iron have been detected in the SNc of PO individuals 
(Dexter et a/., 1987; Saggu eta/. , 1989; Sofie eta/. , 1992). Long before any genetic 
linkages were discovered for PO, oxidative stress was known to be involved in its 
etiology. 
A relationship appears to exist between a-Syn toxicity and oxidative stress. 
Recent studies suggest that a-Syn localizes to the mitochondria and may be involved in 
organelle maintenance (Parihar eta/. , 2008; Shavali eta/., 2008; Parihar eta/., 2009). 
Human DA neuroblastoma cells overexpressing a-syn show signs of increased oxidative 
stress, including increased ROS production and lipid peroxidation, believed to be the 
result of mitochondrial dysfunction. Increased expression of oxidative stress biomarkers 
was also evident in pluripotent stem cell (iPSC)-derived DA neurons ti·om PO patients 
with an a-syn triplication (Byers eta/., 20 II). Studies in Drosophila have revealed that 
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mutant a-syn-induced toxicity is enhanced under conditions ofhyperoxia (Botella el a/., 
2008). The combination of excess a-Syn and oxidative stress appears to play an 
important role in the progression of PO, although, the pathogenic mechanism remains 
unclear. 
The Drosophila a-sy nuclein model of Parkinson disease 
Drosophila melanogaster has been used extensively as a model organism over the 
past century due in large part to its short generation time (roughly I 0 days from egg 
deposition to adult) and low cost. Many genetic tools have been developed for this tiny 
insect. One such tool used frequently in Drosophila disease models is the UAS/Ga/4 
directed expression system (Brand and Perrimon, 1993). Gal4 is a potent activator of 
transcription in yeast whose DNA binding and transcriptional activation have been well 
characterized (Ptashne, 1988). Endogenous binding sites for Gal4 are not found in the 
Drosophila genome, however it can be used to activate transcription in flies when Gal4 
binding sites are inserted within their transcription control regions (Fischer e / a/., 1988). 
Gene expression can be manipulated spatially and temporally when Ga/4 fused to a 
Drosoph i Ia promoter and its target upstream activating sequence ( UA S) are both present 
in the fly genome. The first step towards achieving directed expression is to construct 
two stable lines: one containing Ga/4 fused to a tissue-specific promoter, and a second 
with VAS e lements inserted upstream of a gene of interest. Crosses are designed with the 
goal of collecting progeny with at least one copy of each gene construct. When 
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combined, Ga14 produced in the designated tissue can bind to the UAS and activate 
transcription of the gene under study (Figure 2). The UAS/Ga/4 system functions at 
standard temperatures (i.e. does not require a heat shock) and fac ilitates the study o f toxic 
gene products as stable lines can be created prior to Ga/4 introduction. The same cannot 
be said for prev iously used Drosophila expression systems making the UAS/Ga/4 system 
a superior choice. 
The first Drosophila model o f PD was developed in 2000, 3 years after the 
characterization of a-syn as a disease risk factor. Feany and Bender made use o f the 
UAS/Ga/4 system to overexpress both WT and mutant human a-sy n in Drosophila 
neurons (Feany and Bender, 2000). Their a-sy n model recapitulated several key PD 
symptoms in fli es, including progressive loss of DA neurons, locomotor dysfunction, and 
the presence of LB-Iike inclus ions containing a-Syn. Additionally, enhanced a-sy n 
expression in the eye, another Drosophila tissue rich in neurons, caused retinal 
degeneration. Studies using this model from our laboratory have demonstrated that a-syn 
overexpression at e levated temperatures disrupts the external morphology of Drosophila 
eyes (Todd and Staveley, 2008). Such Drosophila overexpression mode ls provide a 
versati le framework for the study of diseases involving increased gene copy number or 
protein aggregation. When investigating neurodegenerative d isorders like PD, a 
researcher can easily quantify cell survival and rapidly evaluate the therapeutic value of 
new treatments w ith a Drosophila mode l. 
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Protein 
Figure 2- Directed gene expression in Drosophila via the UA S/Ga/4 system. VA S-
contro lled transcription remains inactive when the two transgenes are isolated in the 
parental generation (P 1 ) . The Ga l4 transcription factor binds to the UAS responsive DNA 
elements in progeny wi th at least one copy of each transgene (F 1) activating tissue-
specific transcription of the gene under study. TSP: tissue specific promoter, UA S: 
upstream activating sequence, GO/: gene of interest. Blue ova ls represent Ga l4 protein. 
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Antioxidants prolong l[fespan and improve Parkinson disease-related phenotypes in 
Drosophila 
Studies using Drosophila as a model organism have revealed a great deal 
concerning the effects of antioxidants upon lifespan. Both intrinsic and upplemented 
antioxidants have been found to prolong lifespan in flies. SOD and catalase (CAT) are 
examples of endogenous antioxidant enzymes in Drosophila that functi on together to 
convert 0 2• - into water via an H20 2 intern1ediate (Figure 3). Increased expression of both 
Sod/ and Sod2, typically located in the cytoplasm and mitochondria, respectively, in 
Drosophila motor neurons dramatica lly increased li fespan (Parkes eta/., 1998; Phillips et 
a/. , 2000). In striking contrast to Sod, a similar result was not found for targeted 
expression of Cat in the same cells. In addition to revealing that intrinsic antioxidant 
enzymes protect against ageing, these results suggested that enzymes like SOD and CAT 
are of varyi ng importance in neurons despite functioning in the same pathway. 
Exposing Drosophila to a supplemented diet is re latively easy considering they 
li ve and breed on their food source in the laboratory setting. xtracts of many common 
dietary sources of antiox idants have prolonged survival in Drosophila including: i) whole 
food extracts from apple, nectarine, and cocoa (Bahadoran i and Hilliker, 2008; Boyd et 
a/. , 20 II ; Peng et a/. , 20 II ), ii ) tea extracts including green tea catechins and black tea 
(Li eta/. , 2007; Peng el a/. , 2009), iii) the traditional herbal medicines Stachys 
lavandulifolia and Aloe vera (A I tun et a/. , 20 I 0; C handrashekara and Shakarad, 20 II ), 
and iv) individual chemical compounds such as ascorbic acid and resveratrol (Bahadorani 
et a/. , 2008). Thanks to its rapid generation time, establi shed genetic tools, 
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SOD CAT 
Figure 3 - Schematic of the superoxide dismutaselcatalase antiox idant pathway. 
Superoxide (0 2· -) is converted to water (H20 ) via a hydrogen perox ide (H20 2) 
intermediate. SOD: superoxide di smutase, CAT: cata lase. Red text denotes reactive 
oxygen species. 
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and simple food delivery, Drosophila has played an instrumenta l role in uncovering the 
effects of antioxidants on lifespan. 
Increased antioxidant protection has been found to improve PD-related 
phenotypes in Drosophila. Co-expression of antioxidant enzymes like 111ethionine 
sulfoxide reductase A (MSRA) and human Sod I improve DA neuron survival and protect 
against premature decreases in climbing ability induced by excess a-Syn in Drosophila 
DA neurons (Wassef eta/. , 2007; Botella eta/., 2008). The protective e ffect of 
mitochondrial chaperone tumor necrosis factor receptor-associated protein I (TRAP I) 
against oxidative stress is dependent on phosphory lation by PTEN-induced putative 
kinase I, or PfNK I (Pridgeon eta/. , 2007). Coincidentally, directed co-expression of the 
two aforementioned genes with o.-syn in Drosophila improves DA neuron survival , eye 
degeneration, and locomotor de ficienci es (Todd and Staveley, 2008; Butler eta/. , 20 12). 
Supplementing Drosophila food medium with dietary antioxidants has shown promise as 
well. Medi um supplemented with grape extract improved both early mortality and the 
premature decline in locomotion in a Drosophila model of PO (Long et a/. , 2009). 
Though the literature is relatively new, the interest in potential antioxidant therapies for 
treating PO has increased thanks in large part to studies using Drosophila as a model 
orgamsm. 
In this study, I hypothesized that increased protection against oxidative stress in 
Drosophila DA neurons could both prolong lifespan and protect against a.-.syn-induced 
degenerati ve phenotypes. I used a combination of longevity assays, locomotion assays, 
and biometric ana lyses to obtain the results. First, I produced additional evidence that 
directed expression of intrinsic antioxidant enzymes in Drosophila neurons extends 
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lifespan. Secondly, I investigated the protective properties of blueberry extract (BBE) 
supplementation in the Drosophila a.-syn model of PD. Blueberries are an excellent 
source of dietary antiox idants. High-performance liquid chromatography analysis has 
identifi ed 18 phenolic compounds in blueberries, which combined had the second highest 
total antioxidant activity in a cohort o f tested berries including cranberries, raspberries, 
black currants, and red currants (Borges et a/. , 20 I 0). Here I report that supplementation 
with Webber Natura ls' 36: I concentrate BB E improves severe cases o f early mortal ity 
and eye degeneration caused by directed expression of a.-syn in the DA neurons and 
developing eye, respectively, of D. melanogaster. 
MATERIALS AND METHODS 
Drosophila stocks and culture 
The VAS-a.-synuclein (Feany and Bender, 2000) and Ddc-Gal4 (Li eta/., 2000) 
fl ies were generously provided by Dr. M. Feany (Harvard Medical School) and Dr. J. 
Hirsh (U niversity of Virginia), respecti vely. Each of the VAS-Sod/ (Parkes e/ a/. , 1998), 
VAS-Sod2 (Anderson et a/. , 2005), and VAS-Cat (Anderson et a/., 2005) stocks were kind 
gifts from Dr. John P. Phillips (Uni versity of Guelph). T he GMR-Gal4 (Freeman, 1996), 
VAS-IacZ (Brand and Perrimon, 1993), VAS-GFP (Dickson, 1996), and w1118 tl ies were 
18 
obtained from the Bloomington Drosophila Stock Center at Indiana University. Directed 
expression of the transgenes in DA neurons and during early eye development was 
accomplished by crossing homozygous Ddc-Gal4 and GMR-Gal4 females, respectively, 
to males homozygous for a VAS-controlled transgene. For the antioxidant enzyme 
overexpression experiments, homozygous Ddc-Gal4 Ill (on the third chromosome) 
females were crossed to homozygous UAS-a.-synuclein (PO mode l), UAS-IacZ (control ), 
UAS-GFP (control), UAS-Sodl , UAS-Sod2, and UAS-Cat males. For the BB E-
supplementation experiments, homozygous UAS-a.-synuclein (PO mode l) and UAS-IacZ 
(control) males were crossed to fema les homozygous for Ddc-Ga/4 II (on the second 
chromosome), Ddc-Ga/4 Ill, or GMR-Ga/4. Two additional control lines lacking a UAS-
regulated transgene were generated by crossing homozygous Ddc-Ga/4 or GMR-Ga/4 
females to 1V1 118 males. All crosses were performed as per standard methods. The 
resulting genotypes were: I) IV1118 ; UAS-a.-sy nuclein/Ddc-Gal4, 2) IV1118 : UAS-a.-
synucleinl+: Ddc-Gal41+, 3) w1118 ; UAS-/acZIDdc-Ga/4, 4) IV11 18 : UAS-IacZI+ : Ddc-
G I 111s I d G I ) 111s d I ) ' ' ' s S a/4 + , 5) IV ; + D c- a 4, 6 1v : +: D c-Ga/4 + , 7 w : UA -a.-
sy nuc/einiGMR-Ga/4, 8) 1V1118 ; UAS-/acZIGMR-Ga/4, 9) w1118 ; UAS-GFPI : Ddc-
Ga/41 I, I 0) IV1118 : UAS-Sodl/+; Ddc-Ga/41+, II ) 1v 1118 : UAS-Sod21+: Ddc-Ga/41+, and 
1118 C I I 12) IV : UAS- at +; Ddc-Ga/4 + . 
Flies were fed either a standard cornmeal-yeast-molasses-agar medium (65 g/ L 
commeal, 15 g/L nutritiona l yeast extract, 5.5 g/L agar, 50 ml/L fancy grade molasses in 
water supplemented with 0.1 g/ml methy l paraben in ethanol and 2.5 ml proprionic acid) 
or standard medium supplemented with Webber Naturals' 36: I concentrate BBE (WN 
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Pharmaceuticals® Ltd., Coquitlam, B.C., V3K 785, www. webbernaturals.com). BBE-
supplemented media was produced by adding I or 5 g/L BBE to the above recipe during 
media preparation. 
Longevity assay 
Flies were collected under gaseous carbon dioxide (C02) every 24 hours until a 
minimum of two hundred adult males of each genotype were obtained. They were then 
transferred to upright standard plastic shell vials containing standard cornmeal-yeast-
molasses-agar medium (control), or standard medium supplemented with either I mg/ml 
BBE or 5 mg/ml BBE. Each group was maintained at 25 oc and kept in non-crowded 
conditions (:S20 individuals initially per vial). Flies were scored for viability every 2 days 
and transfen·ed to fresh medium without anesthesia according to established protocol 
(Staveley el a/., 1990). Survival fractions were calculated in Prism version 5.0b for Mac 
OS X (GraphPad Software, San Diego California USA, IVWiv.graphpad.com) using the 
product limit (Kaplan-Meier) method. 
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Locomotion assay 
Fifty adult ma les of each genotype were assayed for cl imbing ability as described 
previously (Todd and Staveley, 2004). Flies were collected every 24 hours under gaseous 
C0 2 and transferred to upright standard plastic shell via ls containing standard cornmea l-
yeast-molasses-agar medium (control), or standard medium supplemented with either I 
mg/ml BB E or 5 mg/ml BB E. Flies were maintained and assayed in groups of I 0 
individuals. Flies were g iven 48 hours to recover from the anesthesia be fore first be ing 
assayed. C limbing ability was measured again when fli es reached 8 days o ld and 
repeated every 7 days foll owing this po int. C limbing abili ty was determined using an 
apparatus consisting of a 30 em long clear glass tube with a diameter of 1.5 em (F igure 
4). T he bottom ofthe tube was marked off into five 2 em sections with the remaining 20 
em of the tube acting as a buffer zone that limits interference between individuals during 
climbing. A funnel was used to transfer tlies to the apparatus and also doubled as a base. 
Sponges were inserted into both ends of the g lass tube to both prevent tlies from escaping 
and a llow gas exchange to occur. During ana lysis, tlies were gently tapped to the bottom 
o f the apparatus and g iven I 0 seconds to climb. Each individual was g iven a score based 
on the highest section they reached. Flies were scored I 0 times per trial and a climbing 
index was calculated with the fo llowing formula: 
C limbing index = L: (nm) I N 
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Sponge 
Gla tube 
Buffer zone 
2 em sections 
Base/Funnel 
Figure 4- Schematic representation of the graded climbing apparatus. The structure 
consists of a 30 x 1.5 em glass tube sea led at both ends by sponges. The bottom of the 
tube is di vided into five 2 em sections with an ascending score ( 1-5) and the rema inder of 
the upper portion serves as a buffer zone. A funne l acts as both a base for the tube and a 
means of transferring fli es to and from the apparatus (modified from Todd and Staveley, 
2004). 
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where n is the total number of flies at a g iven leve l, m is the score for that level (I - 5), 
and N is the total number of flies assayed for that trial. Data were analyzed in Prism 
version 5.0b for Mac OS X (GraphPad Software, San Diego California USA, 
www.graphpad.com). To compare climbing ability, climbing indices were subtracted 
from 5, to compensate for inverting they-axes of the graphs, followed by a non-linear 
curve regression analysis. The slopes of curves with non-overlapping 95% confidence 
intervals (C l) were deemed significantly different. 
Scanning electron microscopy and biometric analyses 
Flies were reared and aged 3 to 5 days post-eclosion on either standard or BBE 
supplemented medium at 25 or 29 °C. Surviving flies were preserved at -80 oc before 
being mounted on metal studs under a dissecting microscope. Prepared fl ies were 
desiccated overnight and gold coated prior to photography at 170 ti mes magn ification 
with a Hitachi S-570 scanning electron microscope. 
All biometric measurements were conducted with the aid of the software package 
lmageJ64 version 1.42q (Abramoff eta/. , 2004). The area ofa single ommatidium was 
determined by measuring the average area of a "floret" of ommatidia, consisting of a 
central unit surrounded by s ix others, then dividing by 7. These numbers were used to 
distinguish between normal and atypical ommatidia when measuring percent disruption. 
A disrupted or atypical ommatidium was defined as having an area 50% smaller or 150% 
larger than a typical ommatidium for that condition. An oval with an area between 
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35000-40000 flm2 was overlaid on the apex ( flattest portion) of each analyzed eye with 
Paintbrush version 2. 1. 1 for Mac OS X (Copyright © 2007-20 I 0 Soggy Waffles). 
Individual areas of disruption within the oval were measured in triplicate and a percent 
value was obtained by dividing the summed average values into the average area of the 
oval (also measured in triplicate). This protocol was modified from similar measures 
previously performed in our lab (Todd and Staveley, 2008). Ten individuals were 
evaluated in the percent disruption analysis, whereas 15 individuals from each condition 
were analyzed for ommatidium counts, bristle counts, and measurements of ommatidium 
area. Bar graphs were produced using Prism version 5.0b for Mac OS X (GraphPad 
Software, San Diego California USA, w1v1v.graphpad.com). 
RESULTS 
Directed expression ofcatalase in D. melanogasler dopaminergic neurons slight~v 
prolongs lifespan 
The damage caused by excess ROS is implicated in senescence and chronic 
pathologies. Previous findings have shown that directed expression of both Sod I and 
Sod2 in Drosophila motorneurons prolongs adult li fespan, whereas Cat has been 
demonstrated to have no effect (Parkes eta/., 1998; Phillips et a/. , 2000). As both 
ox idative stress and DA neuron survival have strong connections with PO pathology, I 
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investigated the effect of increasing intrinsic antioxidant defenses in DA neurons on D. 
melanogaster lifespan. Enhanced expression of Cat in the DA neurons slightly prolonged 
lifespan in flies as compared to both control lines (Figure 5A). Flies expressing Cat had a 
median survival of 80 days whereas lacZ- and GFP-expressing flies had values of 76 and 
74 days, respectively. In contrast to the results found in motorneurons, ne ither Sod I nor 
Sod2 were found to significantly extend lifespan when their expression was enhanced in 
DA neurons (Figure 5C & D). Additionally, increased a-syn expression in D. 
melanogaster DA neurons resulted in a median survival of 70 days and did not differ 
s ignificantly from either control line (Figure 58). Median survival times for each 
genotype are presented in Table 4. The effect of Cat, Sod I, and Sod2 expression on 
Drosophila lifespan appears to be cell-specific as results differ between varying groups of 
neurons. 
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Figure 5 - Directed expression of catalase in the dopaminergic neurons s lightly extends 
lifespan in D. melanogaster. A The longevity of flies expressing Cat is significantly 
longer than both the lacZ- and GFP-expressing controls (p < 0 .05). B- 0 Flies 
expressing o..-synuclein, Sod/, or Sod2 in their DA neurons have a median survival time 
comparable to the contro l lines when expression is driven by Ddc-Ga/4 on the third 
11/H //IN 
chromosome. Genotypes are w : UAS-Catl+: Ddc-Ga/41+ (CAT, n = 240), H ' : 
UAS-o..-synucleinl+: Ddc-Ga/41+ (aSYN, n = 257), w1118 : UAS-Sod/1+: Ddc-Ga/41+ 
So 9 1118 S d I d G I O 1118 ( Dl , n = 26 ), w : UA -So 2 +: D c- a/4 + (S 02, n = 225), w : UAS-IacZI+ : 
Ddc-Ga/41+ (LACZ, n = 241), and w1118: UAS-GFPI+: Ddc-Ga/41+ (GFP, n = 303). 
Error bars represent standard error of the mean. p-values were ca lculated by the log-rank 
(Mantel-Cox) test and multiple comparisons were conected fo r using the BonferToni 
method. 
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Table 4 - Median survival values of D. melanogaster w ith elevated neuronal levels of 
enzymatic antioxidants or a-sy nuclein 
Genot e Median survival ( da s) 
I V 
1118 
: UA S-/acZI+: Ddc-Ga/4/+ 76 
w
1118
: UAS-GFPI+; Ddc-Ga/4/ 74 
IV
1118
: UAS-a-syn/+; Ddc-Ga/4/+ 70 
1/ /8 
: UA S-Sod/1+; Ddc-Ga/41+ 78 I V 
11 18 ; UAS-Sod2/+; Ddc-Ga/4/ 70 I V 
IV 
1118 
: UA S-Catl+: Ddc-Ga/4/+ so· 
* ind icates a va lue found to be s ig nificantly diffe re nt (p < 0 .05) than both the /acZ and GFP control 
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The severity of a-synuclein-induced reductions in lifespan depends on Ddc-Ga/4 
Differing results have been documented concerning the e ffect of increased 
neuronal amounts of a-Syn on Drosophila lifespan. Initially, pan-neural expression of a-
syn was reported to not alter lifespan in flies, whereas a later study described an a-syn-
induced decrease in lifespan in a similar PD model (Feany and Bender, 2000; Wassef et 
a/. , 2007). The results presented herein agree with the latter study as enhanced 
expression of a-syn in Drosophila DA neurons produced a reduction in survival times 
(Figure 6). The severity of the aforementioned effect appears to be dependent on the 
genomic location of the Ddc-Gal4 transgene. Flies expressing a-syn with the Ddc-Ga/4 
transgene located on the second chromosome (Ddc-Gal4 If) had a severely reduced 
lifespan compared to control lines; their median survival time being 52 days as compared 
to 82 in flies without a responsive transgene (1V 1118 ) and 74 days in controllacZ-
expressing fli es (Figure 6A). A less pronounced reduction in survival time was observed 
when Ddc-Gal4 on the third chromosome (Ddc-Gal4 Iff) was used to drive a-syn 
expression (Figure 6B). Flies containing Ddc-Gal4 Ill combined with e ither UAS-a-syn, 
UAS-IacZ, or no UAS transgene ( 1V11 18 control) had median survival times of 70, 82, and 
78 days, respectively. Table 5 contains the median surviva l time values for both 
categories of Ddc-Gal4 fli es. Positioning appears to have a more signiticant effect on 
transgene expression than initia lly believed as a-syn-induced mortality differs greatly 
between Ddc-Gal4 II- and Ddc-Gal4 ///-containing flies. 
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Figure 6 - o..-.\ynuclein reduces lifespan in D. melanogaster when expressed in the 
dopaminergic neurons. A Flies have a severely reduced li fespan when o..-.synuclein 
expression in the OA neurons is driven by Ddc-Ga/4 II (p < 0.05). n = 227, 2 18, and 229 
for aSYN/Odc II , LACZ/Odc II and w 111R; Ode II , respectively. B o.-synuclein expression 
in the OA neurons driven by Ddc-Ga/4 Il l produces a less severe, yet significant, 
reduction in D. melanogaster li fespan (p < 0.05). n = 229, 254, and 240 for aSYN; Ode 
Ill , LACZ; Ode Ill , and w 111 x;+; Ode Ill , respectively. Genotypes are v. ./ 118: UAS-a-
::,ynuc/ein/Ddc-Ga/4 (aSYN/Odc II) , w1118; UA S-/acZ/Ddc-Ga/4 (LACZ/Odc II), w11 18: 
+/Ddc-Ga/4 (w 111 x; Ode II ), w1118; UAS-a-synucleinl+; Ddc-Ga/41+ (aSYN ; Ode Ill), 
1118 ~; I d 1118 ..J G I IIIX d w ; UAS-IacZ +: Ddc-Ga/4 + (LACZ; Ode Il l), an w :+:Due- a/4 + (w ; 0 c 
Ill ). Error bars represent standard error of the mean. p-values were calculated by the log-
rank (Mantel-Cox) test and multiple comparisons were corrected for using the BonferToni 
method. 
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Table 5 - Median survival values for D. melanogaster with a-synuclein expression 
directed to their dopaminergic neurons 
Genotype Median survival (days) 
'''s I d G I w : + D c- a 4 74 
w
1118
; UAS-IacZ/Ddc-Gal4 82 
1118 S I d G I I V ; UA -a-sy n D c- a 4 
'''s d G l I 1v : +: D c- a 4 + 78 
w
1118
: UAS-IacZ/+; Ddc-Gal4/+ 82 
w
1118
; UAS-a-sy nl+: Ddc-Gal4/+ 
* indicates a va lue that was deemed s ignificantly different (p < 0.05) from both the /acl and 11 ,1 118 control 
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Pre-eclosion exposure to a blueberry extract-supplemented diet partial~v rescues severe 
a.-synuclein-induced decreases in D. melanogaster lifespan 
The relationship between oxidative stress and several neurodegenerative disorders 
has invoked interest in the potential therapeutic benefits of dietary antioxidants. Studies 
of both individual polyphenolic compounds and plant extracts have shown promise in 
several PO models (Long eta/. , 2009; Caruana eta/., 20 I I; Kim eta/., 20 I I) and 
blueberries are known to be a rich dietary source ofpolyphenols (Borges eta/., 2010). 
Figure 7 A shows that a.-syn-expressing tlies with a severely reduced lifespan (aSYN/Odc 
II) exposed to food medium supplemented with BBE survived longer than those fed 
control medium. A diet containing 5 mg/ml BBE significantly extended the median 
survival time of aSYN/Odc II fli es from 52 (control) to 60 days. Similar results were not 
observed when D. melanogaster food medium was supplemented with I mg/ml BB E. 
BBE supplementation did not improve a.-syn-induced early mortality in flies with 
a moderate decrease in lifespan (aSYN; Ode III). Neither I mg/ml nor 5 mg/ml ofBBE 
extended median survival time in aSYN; Ode Ill flies (Figure 78). Median survival time 
values for a ll a.-syn-expressing fli es can be found in Table 6. Extrins ic antioxidants 
provided via BBE supplementation appear to only benefit individuals with severe a.-S.1'17-
induced increases in mortality. 
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Figure 7 - Pre-eclosion blueberry extract supplementation benefits a -.synuc/ein-expressing 
D. melanogaster with severely reduced lifespans. A Fl ies expressing a-svnuclein in their 
DA neurons via Ddc-Ga/4 II that were reared on a diet containing 5 mg/ml BBE survived 
significantly longer than those given a standard diet (p < 0.05). A simi lar effect was not 
found with flies reared on medium containing I mg/ml BBE. n = 227, 267, and 283 for 
control, I mg/ml BBE, and 5 mg/ml BBE medium, respectively. 8 BBE supplementation 
had no effect on lifespan in D. melanogaster expressing a-synuc/ein via Ddc-Ga/4 Ill. n 
= 229, 238, and 265 for control, I mg/ml BBE, and 5 mg/m l BBE medium, respectively . 
X denotes mg/ml. Genotypes are w11 18: UA S-a-sy nuc/ein/Ddc-Ga/4 ( aSYN/Ddc II) and 
w
1118
: UAS-a-synuc/einl +: Ddc-Ga/4/+ (aSYN ; Ddc Ill ). Error bars represent standard 
eJTor of the mean. p-values were calculated by the log-rank (Mantel-Cox) test and 
multiple comparisons were COJTected for using the Bonferroni method. 
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Table 6 - Median survival values for a-synuclein-expressing D. me/anogaster fed either a 
standard or blueberry extract-supplemented medium pre-eclosion 
Genot e (food medium) Median survival (da s) 
w
1118
: UAS-a-sy niDdc-Ga/4 (control) 52" 
w
1118
: UAS-a-sy niDdc-Ga/4 (I mg/ml BBE) 54" 
w
1118
: UAS-a-sy niDdc-Ga/4 (5 mg/ml BB E) 
ttt8 I G I IV ; UAS-a-syn +: Ddc- a/4 + (control) 70' 
w
1118
: UAS-a-sy nl+ ; Ddc-Ga/41+ ( I mg/ml BB E) 66" 
1118 I d G I I w : UAS-a-sy n +: D c- a/4 + (5 mg ml BBE) 
Diffe rent superscripted leners indicate a s ignificant diffe rence (p < 0.05) between vn lues lorn particular 
genotype; comparisons were not made between eli ffe rent genotypes 
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Pre-eclosion blueberry extract supplementation decreases lifespan in D. melanogaster 
with enhanced lacZ expression in their dopaminergic neurons 
The lacZ gene encodes the enzyme ~-galactosidase and is a portion of the lac 
operon found in Escherichia coli. The ~-galactosidase protein hydrolyses lactose to 
galactose and glucose and is perce ived as a harmless reporter gene when inserted into 
other organisms. In this experiment, D. melanogaster with enhanced lacZ expression in 
their DA neurons were used as a control line to compare against results from flies 
expressing a-syn in the same region. Unexpectedly, lacZ-expressing fli es fed SSE-
supplemented medium prior to eclosion had significantly reduced lifespans compared to 
those fed a control diet (Figure 8). D. melanogaster containing Ddc-Gal4 II (LACZ/Ddc 
II) and Ddc-Ga/4 Ill (LACZ; Ode Ill ) both experienced a similar reduction in survival. 
Median survival time for LACZ/Ddc II fli es dropped from 82 days for those fed control 
medium to 72 and 70 days when fed I mg/ml and 5 mg/ml SSE-supplemented medium, 
respectively (Figure 8A). The median lifespan for LACZ; Ode Ill flies was also 82 days, 
however the median survival times produced by I mg/ml and 5 mg/ml SSE 
supplementation for this genotype were 74 and 76 days, respectively (Figure 8S). 
The effect of SSE supplementation on lifespan was further tested with D. 
melanogaster lacking a VAS-controlled transgene. Flies administered either 
concentration of SSE supplementation produced survival curves similar to those of the 
same genotype fed a control medium (Figure 8C & D). The median survival times for 
transgene-Iess D. melanogaster with Ddc-Gal4 II (w 111 8; Ode II ) fed either control , I 
mg/ml SSE, or 5 mg/ml SSE were 74, 76, and 76 days; whereas those for Ddc-Ga/4 Ill 
34 
(w 111 8; Ode Ill) were 78, 76, and 76 days, respectively. The median survival values for 
lacZ and 1v 1118 flies are found in Table 7. The detrimental effects of BBE 
supplementation on lifespan are contined to flies with enhanced expression of lacZ in 
their DA neurons. Exposure to a dietary source rich in polyphenol antioxidants early in 
development combined with excess ~-galactosidase in the DA neurons may harm 
Drosophila. 
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Figure 8 - Pre-eclosion blueberTy extract supplementation shortens lifespan in D. 
melanogaster expressing lacZ in their dopaminergic neurons. A, B Both lines of /acZ-
expressing flies had shorter median survival times when reared on a diet containing BBE 
as compared to those reared on a standard diet (p < 0.05). n = 218, 228, and 225 for 
LACZ/Odc II flies and 254, 272, and 255 for LACZ; Ode Ill fl ies fed control, I mg/ml 
BBE, or 5 mg/m l BBE medium, respectively. C, D BBE supplementation d id not affect 
the longevity of w 1118 control flies . n = 229, 282, and 298 for w 111 x; Ode II fli es and 240, 
260, and 249 for w 111 x; Ode Ill flies fed control, I mg/ml BBE, or 5 mg/ml BBE medium, 
respectively. X denotes mg/ml. Genotypes are w1118; UAS- /acZ/Ddc-Ga/4 (LACZ/Odc 
II), w 1118: UAS-IacZI+: Ddc-Ga/4/ + (LACZ; Ode lll), y, / 118: +/Ddc-Ga/4 (w 111 x; Ode II), 
and w1118: +: Ddc-Ga/4/+ ( w 111 x; Ode I I I). Error bars represent standard erTor of the 
mean. p-values were calculated by the log-rank (Mantel-Cox) test and multiple 
comparisons were corrected for using the Bonferroni method. 
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Table 7- Median survival values of /acZ-expressing and responsive transgene-lacking 
control lines fed either standard or blueberry extract-supplemented food 
medium pre-eclosion 
Genot e (food medium) 
w
1118
: UAS-/acZ/Ddc-Ga/4 (control) 
Ill~ 
1v ' : UAS-/acZ/Ddc-Ga/4 ( I mg/ml BBE) 
1v
1118
: UAS-/acZ/Ddc-Ga/4 (5 mg/ml BB E) 
1118 I d G I I w : + D c- a 4 (contra ) 
w
1118
: +/Ddc-Ga/4 ( I mg/ml BBE) 
w
1118
: +/Ddc-Ga/4 (5 mg/ml BB E) 
w
1118
: UAS-IacZI : Ddc-Ga/4/+ (control ) 
w
1118
; UAS-IacZI+; Ddc-Ga/4/+ ( I mg/ml BBE) 
w
1118
: UAS-IacZI+; Ddc-Ga/4/+ (5 mg/ml BBE) 
w
1118
: +: Ddc-Ga/41+ (control) 
w
1118
; +: Ddc-Ga/4/+ ( I mg/ml BB E) 
1v
1118
: +: Ddc-Ga/4/+ (5 mg/ml BB E) 
Median survival (da s) 
82" 
7i' 
70" 
78r 
76g, 
761!;, 
Diffe rent superscripted le tters indicate a s ig nificant difference (p < 0.05) between va lues fo r a particular 
genotype; comparisons were not made between different genotypes 
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Post-eclosion blueberry extract supplementation does not ameliorate a-synuclein-induced 
early mortality in D. melanogaster 
As PO is a progressive disorder that typically manifests in older individuals, 
transfening D. melanogaster to BBE-supplemented food after they had eclosed as adults 
was used to mimic a treatment plan that could be implemented later in li fe. Flies were 
bred on control food and were first exposed to a BBE-supplemented diet within 24 hours 
of reaching adulthood. BBE supplementation later in D. melanogaster development did 
not improve the shortened lifespan caused by excess a -Syn in OA neurons. The median 
survival time of aSYN/Odc II flies was 46 days for each food medium (Figure 9A), 
whereas aSYN; Ode Ill flies fed control, I mg/ml BBE, or 5 mg/ml BBE medium had 
median survival times of 54, 54, and 52 days, respectively (Figure 9B). Contrary to the 
results discovered for pre-eclosion supplementation, BBE does not seem to counteract a -
.syn-induced declines in lifespan when administered following eclosion. 
Post-eclosion BBE supplementation inlacZ-expressing flies produced the 
opposite results to those found for pre-eclosion supplementation. Flies expressing lacZ 
first exposed to BB E supplementation in adulthood survived slightly longer than those fed 
a control medium. Only 5 mg/ml BBE s ignificantly prolonged the median survival time 
of LACZ/Odc II flies (Figure I OA). Those fed a high concentration of BB E had a 
survival time of 60 days compared to 58 for individuals fed control medium. In the case 
of LACZ; Ode Ill flies, both concentrations of BB E-supplemented medium prolonged 
lifespan (Figure I OB). The median survival time increased from 52 days for fli es fed 
control medium to 56 days for individua ls that received either I mg/ml or 5 mg/ml BBE-
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supplemented medium. Table 8 contains median surviva l values generated from the post-
eclosion BBE supplementation experiment. Contrary to pre-eclosion supplementation, 
de layed exposure to a BBE-supplemented diet improved the longevity of /acZ-expressing 
D. melanogasler. This data supports the a forementioned hypothesis that the combination 
of excess ~-ga lactosidase with a die tary source rich in polyphenolic antiox idants is only 
detrimental to individuals early in development. 
Please note that the median survival times obtained during this particular run of 
the experiment are atypical and may re flect a response to an unknown environmental 
condi tion (e.g. temperature change) that is di scussed in Appendix 2. 
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Figure 9 - Post-eclosion blueberry extract supplementation does not affect lifespan in a-
-~ynuclein-expres ing D. melanogaster. A Longevity curves of fli es expressing a-
S.\ nuclein in their OA neurons via Ddc-Ga/4 II fed control (n = 208), I mg/ml BBE (n = 
22 I), or 5 mg/ml BBE (n = I 97) medium. B Longevity curves of fli es expressing a-
synuclein in their DA neurons via Ddc-Ga/4 Ill fed control (n = 233), I mg/ml BBE (n = 
226), or 5 mg/ml BBE (n = 242) medium. X denotes mg/ml. Genotypes are w 11 18: UAS-
a-synuc/ein/Ddc-Ga/4 (aSYN/Ddc II) and w 11 18 : UAS-a-synuclein/+: Ddc-Ga/4/ + 
(aSY ; Ode II I). En·or bars represent standard error of the mean. p-values were 
calculated by the log-rank (Mantel-Cox) test and multiple compari ons were corrected for 
using the Bonferroni method. 
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Figure I 0 - Blueberry extract fed post-eclosion s lightly extends lifespan in /acZ-
express ing D. melanogasler. A Flies expressing lacZ fed 5 mg/ml BBE (n = 129) 
survived significantly longer (p < 0.05) than those fed either a control diet (n = 145) or 
one supplemented with I mg/ml BBE (n = 136) when expression was driven by Ddc-
Ga/4 II. B Diets supplemented with both I mg/ml (n = 297) and 5 mg/ml (n = 33 1) BBE 
significantly extended lifespan (p < 0.05) in flies with lacZ expression in their DA 
neurons driven by Ddc-Ga/4 III as compared to a contro l diet (n = 274). X denotes 
mg/ml. Genotypes are w11111: UAS-/acZ/Ddc-Ga/4 (LACZ/Ddc II ) and w1118: UAS-
IacZI+; Ddc-Ga/4/ + (LACZ; Ode Ill). En·or bars represent standard eJTOr of the mean. 
p-values were calculated by the log-rank (Mantel-Cox) test and multiple comparisons 
were COJTected for using the Bonferroni method. 
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Table 8 - Median survival values for a-synuclein- and /a cZ-expressing D. melanogas/er 
fed either a standard or blueberry extract-supplemented diet post-eclosion 
Genot e (food medium) 
'''s I w ; UA S-a-syn Ddc-Ga/4 (control) 
1v
1118
; UA S-a-syniDdc-Ga/4 ( I mg/ml BBE) 
'' 's S I G I I V ; UA -a-syn Ddc- a/4 (5 mg ml BBE) 
w
1118
; UAS-a-synl+: Ddc-Ga/41+ (contro l) 
1118 S I G I 1v ; UA -a-syn +: Ddc- a/4 + (I mg/ml BBE) 
'' 's S I d I w : UA -a-sy n +: D c-Ga/4 + (5 mg/ml BBE) 
w
1118
; UAS-/acZIDdc-Ga/4 (contro l) 
'''8 I 1v ; UA S-IacZ Ddc-Ga/4 (I mg/ml BB E) 
'''8 I I V : UAS-IacZ Ddc-Ga/4 (5 mg/ml BBE) 
111s I w : UAS-IacZ + ; Ddc-Ga/41+ (control) 
w
1118
; UAS-IacZI+; Ddc-Ga/41+ ( I mg/ml BBE) 
w
11 18
: UAS-/acZI+: Ddc-Ga/41+ (5 mg/ml BBE) 
Median survival (da s) 
Different superscripted letters indicate a s ig nifi cant diffe rence (p < 0 .05) between va lues for a particular 
genotype; comparisons were not made between different genotypes 
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D. melanogasler with enhanced a-synuclein expression in their dopaminergic neurons do 
not prematurely lose climbing ability 
One of the hallmark phenotypes of the Drosophila a-syn PO model is the 
premature loss of c limbing ability in older individuals. Though several labs have 
reproduced thi s result, their protocols and control lines often differ (Haywood and 
Staveley, 2004; Todd and Staveley, 2008; Butler e/ a/. , 20 12; Hillman e/ a/., 20 12). Two 
types of control lines were used in this experiment: one with enhanced ex pression of a 
non-detrimental gene (lacZ) in the DA neurons regulated by VAS, and one lacking a VAS-
contro lled transgene (no upregulated expression). In this experiment, the progressive loss 
of climbing ability in the a-syn PO mode l was similar to the two control lines for both 
aSYN/Odc II and aSYN; Ode Ill fli es (Figure II). The 95% C I of the slopes overlapped 
in each of the three genotypes indicating that any observed differences are likely due to 
chance. A ll statistica l values associated w ith the climbing curves in Figure II are found 
in Table 9. Despite repeated efforts, I was not able to duplicate the premature loss in 
climbing ability observed in the Drosophila a-syn PO model. 
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Figure I I - Targeted a-synuclein expression in the dopaminergic neurons of D. 
melanogaster does not affect locomotion. A Climbing curves for flies containing Ddc-
Ga/4 II. 8 The climbing abili ty of flies expressing a-synuclein was similar to both the 
lacZ and w 1118 controls containing Ddc-Ga/4 Ill. Genotypes are w1118; UAS-a-
synuc/ein/Ddc-Ga/4 ( aSYN/Odc II), w1118 ; UAS-/acZ/Ddc-Ga/4 (LACZ/Odc II), w11 18; 
I d G Ill R 1118 . I +1D c- a/4 (w ; Ode II), w : UAS-a-synuclem +; Ddc-Ga/4/+ (aSYN; Ode Ill), 
w
1118
; UAS-IacZ/+ ; Ddc-Ga/4/+ (LACZ; Ode Il l), and w 11 18: +; Ddc-Ga/4/+ (w 111 x; Ode 
III ). Error bars represent standard error of the mean. C limbing ability was detem1ined 
via non linear curve fit (C I = 95% ). 
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Table 9- Locomotion assay statistics used to compare the climbing abili ty of a-synuclein-
expressing D. melanogaster to a lacZ and responsive transgene- lacking control 
Genotype Slope (k) Standard 95°/o confidence 
error (SE) interval (CI) 
1v
1118
: +/Ddc-Ga/4 0.03376 0.003540 0.02664 - 0.04089 
w
1118
; UAS-/acZ/Ddc-Ga/4 0.04015 0.003221 0.03376 - 0.04653 
w
1118
: UAS-a-syn/Ddc-Ga/4 0.03365 0.003373 0.02704 - 0.04026 
'''s d G I I 1v : +; D c - a 4 + 0.03931 0.002493 0.03433 - 0.04429 
w
1118
: UAS-IacZI+: Ddc-Ga/4/+ 0.03797 0.002566 0.03289 - 0.04305 
w
1118
: UAS-a-syn/+; Ddc-Ga/4/+ 0.03928 0.002859 0.03362 - 0.04495 
* indicates a value that was deemed s ignificant ly different (p < 0.05) from both the locZ and 11,1 118 contro l 
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Blueberry extract supplementation does not improve locomotion in D. melanogaster 1vith 
upregulated a-sy nuc/ein expression in their dopamine,.g ic neurons 
Treatment w ith both intrinsic antioxidant enzymes and antioxidants obtained via 
diet supplementation has improved the premature loss of climbing ability characteristic of 
the Drosophila a-sy n model of PO (Wasse f et a/. , 2007; Bote lla et a/. , 2008; Long et a/. , 
2009). Figure 12 and Table I 0 contain the climbing curves and their associated statistics 
discovered for a -syn-expressing fli es fed either control medium or a diet supplemented 
w ith one of two concentrations of BB E. Ne ither pre-eclosion (Figure 12A & B) nor post-
eclos ion (Figure 12C & D) BBE supplementation improved locomotion in either 
aS YN/Ddc II or aSYN; Ode Ill fli es. Unlike the results found for S-methyi-L-cysteine 
and grape extract supplementation, BBE supplementation up to a concentration of 5 
mg/ml did not a lter c limbing abili ty in the Drosophila a-sy n model of PD. 
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Figure 12 - Blueberry extract supplementation does not affect locomotion in rx-synuclein-
expressing D. melanogaster. A, B Cl imbing curves for a-synuc/ein-expressing flies fed 
BBE-supplemented medium pre-eclosion. C, D Climbing curves for o.-.\ymtclein-
expressing fli es fed BB E-supplemented medium post-eclosion. X denotes mg/ml. 
Genotypes are w1118; UAS-a-sy nuc/ein/Ddc-Ga/4 (aSYN/Ddc II) and H ·1118: UAS-rx-
·\1'111tcleinl +: Ddc-Ga/4/+ (aSYN; Ode Ill ). Error bars represent standard etTor of the 
mean. Climbing abili ty was determined via non linear curve fit (CI = 95% ). 
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Table I 0- Locomotion assay statistics generated from the non-linear curve tit mode l for 
a-synuclein-expressing D. melanogaster fed either control or blueberry 
extract-supplemented medium 
Genotype 
(food medium) 
Pre-eclosion 
w
11 18
; UAS-a-sy niDdc-Ga/4 
(control) 
1118 S I d G I 1v : UA -a-sy n D c- a 4 
( I mg/ml BBE) 
'''s S I d G w : UA -a-sy n D c- al4 
(5 mg/ml BBE) 
w
11 18
: UAS-a-sy nl+: Ddc-Gal41+ 
(control ) 
1118 S I d G I 1v : UA -a-sy n +: D c- a/4 + 
(I mg/ml BBE) 
w
1118
: UAS-a-sy nl+: Ddc-Ga/41+ 
(5 mg/ml BBE) 
Post -eclosion 
1118 S I d G I 1v : UA -a-sy n D c- a 4 
(control) 
1118 S I d G I 1v : UA -a-sy n D c- a 4 
( I mg/ml BBE) 
1118 S I d G I 1v : UA -a-sy n D c- a 4 
(5 mg/ml BBE) 
w
1118
; UAS-a-sy nl+: Ddc-Gal41+ 
(control ) 
w
11 18
: UAS-a-sy nl+: Ddc-Ga/41+ 
(I mg/ml BBE) 
1118 S I d G I 1v : UA -a-syn + ; D c- a/4 + 
(5 mg/ml BBE) 
Slope (k) 
0.03365 
0.04359 
0.03902 
0.03928 
0.03703 
0.04209 
0.03365 
0.03948 
0.03199 
0.03928 
0.05054 
0.05742 
Standard 
error (SE) 
0.003373 
0.005264 
0.004376 
0.002859 
0.002955 
0.003584 
0.003373 
0.003183 
0.004823 
0.002859 
0.005597 
0.006762 
95°/o confidence 
interval (CI) 
0.02704- 0.04026;1 
0.03299 - 0.05418;1 
0.030 19 - 0.04 785;1 
0.03362 - 0.04495 11 
0.031 I I - 0.0429411 
0.03492 - 0.04927 11 
0.02704 - 0.04026c 
0.033 15 - 0.04580c 
0.02238 - 0.04160c 
0.03362 - 0.04495d 
0.03932 - 0.06176d 
0.04382 - 0.071 02d 
Diffe rent superscripted letters indicate a s ig nificant difference (p < 0.05) between va lues lor a particu lar 
genotype; comparisons were not made between different genotypes 
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Post-eclosion blueberry extract supplementation improves locomotion in D. melanogasler 
with upregulated lacZ expression in their dopaminergic neurons 
I have previously described how a diet supplemented with BBE fed post-eclosion 
can extend lifespan in D. melanogaster with enhanced expression of lacZ in their OA 
neurons (Figure 10 and Table 8). LACZ; Ode Ill tlies first exposed to aBBE-
supplemented diet in adulthood also had significantly improved climbing ability 
compared to those fed a control diet (Figure 13 and Table II). A similar result was not 
found for LACZ/Odc II tlies fed post-eclosion or either lacZ genotype fed pre-eclosion. 
The locomotion of tlies fed control medium was also similar to those fed BBE-
supplemented medium for both w1118 control genotypes, though tlies fed 5 mg/ml BBE 
climbed significantly better than those given I mg/ml BB E (Figure 14 and Table 12). 
Post-eclosion exposure to a BBE-supplemented medium appears to improve both survival 
and locomotion in D. melanogaster with upregulated lacZ expression in their OA 
neurons. A beneficial interaction like ly ex ists between increased neuronal amounts of P-
galactosidase and dietary antioxidants ingested during adulthood as evidenced by the 
prolonged lifespan and improved climbing ability during old age in LACZ; Ode Ill flies. 
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Figure 13 - Post-eclosion blueberry extract supplementati on improves mobility in /acZ-
expressing D. me/anogaster. A, B C limbing curves for /acZ-expressing fli es fed SSE-
supplemented medium pre-eclosion. C, D C limbing curves for /acZ-expressing fli es fed 
SSE-supplemented medium post-eclosion. D BB E supplementation post-eclosion 
signi ficantly improved mobility in fli es with lacZ expression directed to the DA neurons 
via Ddc-Ga/4 Ill (p < 0.05). No significant effect was found with any of the other 
categories of fli es (A, B, C ). Genotypes are w 1118 ; UAS- /acZ/Ddc-Ga/4 (LACZ/Ddc II) 
and \,,.1 118: UAS-/acZI+: Ddc-Ga/4/ + (LACZ; Ode Ill). Error bars represent standard 
en or of the mean. C limbing ability was detetmined via nonlinear curve fi t (CI = 95%). 
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Table II - Locomotion assay statistics generated from the non-linear curve fi t mode l for 
/acZ-expressing D. melanogaster fed e ither contro l or bluebetTy extract-
supplemented medium 
Genotype 
(food medium) 
Pre-eclosion 
1v
1118
; UAS-/acZIDdc-Ga/4 
(control) 
IV
1118
: UAS-/acZIDdc-Ga/4 
( I mg/ml BBE) 
IV
1118
: UAS-/acZIDdc-Ga/4 
(5 mg/ml BBE) 
1118 S I G I 1v ; UA -lacZ +: Ddc- a/4 + 
(control) 
1118 S I G I I V : UA -lacZ +: Ddc- a/4 + 
( I mg/ml BBE) 
IV
1118
; UAS-IacZI+; Ddc-Ga/41+ 
(5 mg/ml BBE) 
Post-eclosion 
IV
1118
; UAS-/acZIDdc-Ga/4 
(control) 
IV
1118
; UAS-/acZIDdc-Ga/4 
( I mg/ml BBE) 
IV
1118
: UAS-/acZIDdc-Ga/4 
(5 mg/ml BBE) 
IV
1118
: UAS-IacZI+: Ddc-Ga/41+ 
(control) 
11/ 118; UAS-IacZI+: Ddc-Ga/41+ 
( I mg/ml BBE) 
IV
1118
: UAS-IacZI+ : Ddc-Ga/41+ 
(5 mg/ml BBE) 
Slope (k) 
0.040 15 
0.03506 
0.03570 
0.03797 
0.03570 
0.04309 
0.040 15 
0.05240 
0.05404 
0.03797 
0.05459 
0.06078 
Standard 
error (SE) 
0.00322 1 
0.003090 
0.003278 
0.002566 
0.002854 
0.00340 1 
0.00322 1 
0.005646 
0.006958 
0.002566 
0.0036 11 
0.007640 
95°/o confidence 
interval (CI) 
0.03376- 0.04653:1 
0.02885 - 0.04 126a 
0.029 1 I - 0.04228a 
0.03289 - 0.04305b 
0.02999 - 0.04 14 1 h 
0.03625 - 0.04993h 
0.03376- 0.04653c 
0.04 107- 0.06372(; 
0.04004 - 0.06804c 
0.03289 - 0.04305<1 
0.04 736 - 0.06 183c 
0.0454 1 - 0.076 15c 
Different superscripted letters indicate a s ignificant diffe rence (p < 0.05) between values for a particular 
genotype; comparisons were not made between different genotypes 
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Figure 14- Blueberry extract supplementation does not affect locomotion in D. 
melanogaster that lack a responsive transgene. A, B C limbing curves for flies fed a BBE-
supplemented diet pre-eclosion. X denotes mg/ml. Genotypes are w1 118: +/Ddc-Ga/4 
III X ///8 I IIIR d (w ; Ode II) and w ; +: Ddc-Ga/4 + (w ; D c Il l). EJTor bars represent standard 
error of the mean. Climbing abi li ty was determi ned via non linear curve fit (CI = 95%). 
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Table 12- Locomotion assay statistics generated from the non-linear curve fit model for 
D. melanogaster that lack a responsive transgene fed e ither control or 
blueben·y extract-supplemented medium pre-eclosion 
Genotype Slope (k) Standard 95°/o confidence (food medium) error (SE) interval (CI) 
IV
11 18
: +1Ddc-Gal4 0.03376 0.00354 0.02664 - 0.04089" 
(control) 
II 18 I G I 111 : + Ddc- a 4 0.03009 0.002380 0.02533 - 0.03485" 
( I mg/ml BBE) 
1v
1118
: +1Ddc-Gal4 0.042 10 0.003804 0.03444- 0.04975'1 
(5 mg/ml BBE) 
II 18 d G I I 111 : +: D c- a 4 + 0.0393 1 0.002493 0.03433 - 0.04429bc 
(control) 
Ill s d G I 111 : +; D c- al4 + 0.03 197 0.002442 0.02709 - 0.03685h 
( I mg/ml BBE) 
IV
1118
; +: Ddc-Gal41 0.04956 0.003346 0.04286 - 0.05625c 
(5 mg/ml BBE) 
Different superscripted letters indicate a s ign ificant di fference (p < 0 .05) between val ues lor a particular 
genotype; comparisons were not made between diffe rent genotypes 
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A blueberry extract-supplemented diet does not affect subtle a-synuclein-induced 
phenotypes in D. mefanogaster eyes raised at 25 °C 
The adult Drosophila eye comprises a repeating aiTay of roughly 750 to 800 multi-
cellular subunits known as ommatidia. Each ommatidium is a cluster of20 cells and 
contains 8 photoreceptor neurons, pigment cells, and lens secreting cone cells. 
Mechanosensory bristles are located at alternating vertices of the ommatidia and are 
composed of 4 cells, including a sensory neuron (Kumar, 20 12). Thus, the developing 
eye is another neuron-rich tissue in which a -syn-induced cell death can be eva luated. 
The glass multiple reporter (G MR)-Gal4 construct (Freeman, 1996) causes high-
level expression in Drosophila eye imaginal discs. Flies heterozygous for GMR-Gal4 
have no observable phenotype at 25 °C (Kramer and Staveley, 2003). Though external 
eye morphology appears normal, a-syn expression at 25 oc via G MR-Gal4 causes retinal 
degeneration in flies (Feany and Bender, 2000; Haywood and Staveley, 2004). Figure 15 
displays SEM images of D. melanogaster eyes with increased expression of either lacZ or 
a-syn at 25 °C. Similar to previous results, the external morphology of the eye appears 
normal for both genotypes. Biometric analyses, however, revealed subtle phenotypes 
present at 25 °C that are induced by a-syn (Figure 16). Both the number of ommatidia 
and bristles are reduced in a-sy n-expressing fli es (aSYN). A significant decrease in 
ommatidium number was found for each food medium; however, the decreased amount 
of bristles in aSYN fli es fed control medium was not significant. Supplementation with 
either concentration of BBE was unable to improve these subtle phenotypes and the 
values for both counts are found in Table 13. 
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BBE extract supplementation also appears to affect cell growth in aS Y fli es. 
Individuals exposed to a diet containing 5 mg/ml BBE had significantly larger ommatidia 
than those fed either control or I mg/ml BB E medium (Figure 16C). LACZ flies given 5 
mg/ml BBE in their diet also had larger ommatidia than those fed I mg/ml BBE, however 
a difference was not observed between a control diet and both the aforementioned media. 
Despite the observed differences in ommatidia! area, BB E extract supplementation does 
not appear to affect subtle a -sy n-induced phenotypes in the Drosophila eye. 
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Figure 15 - Expression of a-synuclein during eye development does not produce a visible 
phenotype at 25 °C. A- F Scanning electron micrographs of D. melanogaster eyes with 
elevated amounts of either a-syn (D, E, F) or lacZ (A, B, C) transcript. Both genotypes 
were reared on control (A, D), I mg/ml BBE (B, E), or 5 mg/ml BB E (C, F) medium. X 
denotes mg/ml. Genotypes are w1118; UAS-a-synuc/ein/GMR-Ga/4 (aSYN) and IV11 18: 
UAS-/acZ/GMR-Ga/4 (LACZ). 
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Figure 16 - Blueberry extract supplementation has no effect on moderate o..-.\ynuclein-
induced phenotypes in D. melanogaster eyes at 25 oc. A Enhanced o..-!:>ynuclein 
expression significantly reduces the mean number of ommatidia in D. melanogaster eyes. 
B Increased levels of o..-synuclein reduces the mean number of bristles present in D. 
melanogaster eyes. BBE-supplemented media did not rescue either of the 
aforementioned phenotypes. C o..-synuclein-expressing fli es fed medium supplemented 
with 5 mg/ml BBE had significantly larger ommatidia than those fed either a control diet 
or one supplemented with I mg/ml BBE (p < 0.05). Genotypes are v..l 118 : UAS-o..-
!:>ynuc/ein/GMR-Ga/4 (aSYN) and w1118: UAS- /acZ/GMR-Ga/4 (LACZ). n = 15 for each 
analysis. Error bars represent standard error of the mean. p-values were calculated via 
one-way ANOVA followed by Tukey's Multiple Comparison test. 
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Table 13 - Biometric analyses of the eyes of D. melanogas/er expressing a-synuc/ein or 
lacZ raised at 25 °C 
Genotype 
(food medium) 
1118 s IG G 111 : UA -a-sy nt' MR- a/4 
(contro l) 
1118 
I ll : UAS-a-sy n/GMR-Ga/4 
( I mg/ml BBE) 
1118 S 1G G I ll : UA -a-sy n; MR- a/4 
(5 mg/ml BBE) 
1v
1118
: UAS-/acZIG MR-Ga/4 
(control) 
1/ 118: UAS-/acZ/GMR-Ga/4 
( I mg/ml BBE) 
1v
1118
: UAS-IacZ/G MR-Ga/4 
(5 mg/ml BBE) 
#normal 
ommatidia 
65 1.8 
644.0 
632.8 
695.3 
704.4 
708.9 
58 
#bristles 
505.4 
493.8 
49 1.7 
539.7 
543.4 
548.9 
Ommatidium 
area (J.1m2) 
208.5 
2 12.7 
228.6 
2 14. 1 
207.2 
2 19.6 
Blueberry extract supplementation improves severe a-synuclein-induced degeneration in 
D. melanogaster eyes raised at 29 °C 
Degeneration caused by overexpressing a-syn early in eye development is 
pronounced at higher temperatures. Flies heterozygous for GMR-Gal4 have 
developmental de fects and increased leve ls of apoptosis when raised at 29 uc (Kramer 
and Staveley, 2003). This rough eye phenotype worsens when GMR-Gal4 is used to 
dri ve expression of a-syn in the developing eye (Figure 17D)(Todd and Staveley, 2008). 
Scann ing e lectron micrographs for both aSYN and LACZ fli es fed control, I mg/ml BBE, 
or 5 mg/ml BB E are found in Figure 17. Targeted expression of a-syn at 29 °C increased 
the amount of atypical ommatidia in D. melanogaster eyes (Figure 18A). BBE 
supplementation complete ly rescued this phenotype as the results for aS YN tlies fed 
either concentration o f BBE were comparable to those fo und for LACZ individuals fed 
control medium (Table 14 ). Biometric analyses also revealed an a-~~ 1m-induced decrease 
in bristle number at 29 °C (Figure 18B). Both concentrations o f BB E supplementation 
were suffi c ient to partially rescue the reduced bristle number, increasing the mean bristle 
number from 372.9 in aSYN tlies fed control medium to 4 14.6 and 437.7 fo r those fed I 
mg/ml and 5 mg/ml BBE, respectively. BBE supplementation had no effect on bristle 
number in LACZ fli es, as the mean values for individua ls fed control, I mg/ml BBE, and 
5 mg/ml BBE medium were 541 .3, 543 .6, and 538. 1, respectively. The mean number of 
bristles fo r both genotypes are found in Table 14. These resul ts further support that early 
exposure to a diet supplemented with BB E improves severe a -syn-induced phenotypes in 
a Drosophila model of PD. 
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Figure 17 - a-synuc/ein expression during eye development produces a rough extemal eye 
morphology at 29 oc. A - F Scanning e lectron micrographs of D. melanogaster eyes with 
elevated amounts of either a-synuclein (D, E, F) or lacZ (A, 8, C) transcript. Both 
genotypes were reared on control (A, D), I mg/ml BBE (8 , E), or 5 mg/ml BBE (C, F) 
medium. D Rough extemal eye phenoty pe produced by enhanced expression of a-
synuclein in the developing D. melano~aster eye. Genotypes are w 11 18: UAS-a-
synuc/ein/GMR-Ga/4 (aSYN) and w11 8 : UAS-/acZ/GMR-Ga/4 (LACZ). 
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Figure 18 - Severe degenerative phenotypes in D. melanogaster eyes caused by a-
,\YI1liclein expression at 29 °C are suppressed by a blueberry extract-supplemented diet. A 
Both concentrations of BBE supplementation completely rescued the amount of atypical 
ommatidia caused by enhanced a-synuclein expression (p < 0.05, n = I 0). B BBE 
supplementation partia lly rescues the reduced bristle number in a-synuc/ein-expressing 
eyes (p < 0.05, n = 15). Genotypes are 1v 1118: UAS-a-synuc/ein/GMR-Ga/4 (aSYN) and 
w
11 18
: UAS-/acZ/GMR-Ga/4 (LACZ). Error bars represent standard error of the mean. p-
values were ca lculated via one-way ANOV A followed by Tukey's Multiple Comparison 
test. 
61 
Table 14- Biometric analyses of the eyes of D. melanogaster expressing a-::,ynuclein or 
lacZ raised at 29 oc 
Genotype 
(food medium) 
1118 S /G G I 1v : UA -a-sy n MR- a 4 
(control) 
,, ,8 G 
IV ; UAS-a-sy n/ MR-Gal4 
( I mg/ml BBE) 
'''8 S /G G I 111 : UA -a-sy n MR- a 4 
(5 mg/ml BBE) 
111
1118
; UA S-IacZIGMR-Gal4 
(control) 
w
11 18
: UAS-IacZIGMR-Gal4 
( I mg/ml BBE) 
111s .,c c 111 : UAS-IacZt MR- al4 
(5 mg/ml BBE) 
Atypical ommatidia 
( 0/o area) 
73.5 
40.3 
29.2 
28.9 
N/A 
N/A 
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#bristles 
372.9 
4 14.6 
437.7 
54 1.3 
543 .6 
538. 1 
DISCUSSION 
The longevity-promoting effects of antioxidant enzymes VOfJl between groups of neurons 
Antioxidant enzymes may not provide the same protection in all neurons. I have 
reported that targeted expression of Cat in the DA neurons extends lifespan in D. 
melanogaster (Figure SA). A similar effect, however, was not found for either Sod I or 
Sod2 despite these enzymes participating in the same pathway as Cat. Studies have 
shown that both Sod I and Sod2, but not Cat, extend Drosophila lifespan when their 
expression is directed to motor neurons (Parkes et a/. , 1998; Phillips et a/. , 2000). The 
importance of SOD and CAT acti vity appears to vary between different types of neurons. 
Both PO and motor neuron diseases (MNDs) share ox idati ve stress as a common feature 
of disease etiology. The first genetic linkage associated with amyotrophic lateral 
sclerosis (ALS), the most common adult-onset MND, was determined to be a mutation in 
Sod I, suggesting its activity is essential for the survival of motor neurons. Though a 
mutation in Sod has not been associated w ith PO, ROS are produced during DA neuron 
metaboli sm as the breakdown of dopamine by monoamine oxidase (MAO) produces 
H20 2 (Coyle and Puttfarcken, 1993). Excess CAT may be particularly benefic ial to DA 
neurons since this enzyme converts reactive H20 2 into water and could help protect cells 
against H20 2-induced oxidative damage. Motor neurons and DA neurons vary in the ir 
function, neurotransmitter production, and metabolism. I can, therefore, speculate that 
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the discrepancies between my results and those previously reported for Sod and Cat are 
due to the type of cell in which expression was targeted. 
Dietmy antioxidants can prolong lifespan in Drosophila 
Several recent studies have suggested that Drosophila food medium supplemented 
with a dietary source of antioxidants can prolong lifespan. Adult Drosophila fed extracts 
of nectarine, green tea, black tea, and apple survive longer than those exposed to a 
standard food medium ( Li et a/., 2007; Peng el a/., 2009; Boyd et a/. , 20 I I ; Peng et a/. , 
20 II). I have demonstrated that post-eclosion BB E supplementation extends the li fespan 
of LACZ fli es (Figure I 0). According to the Free Radical/Oxidative Stress Theory of 
Ageing, senescence is a consequence of the accumulation of free radicai/ROS-induced 
damage to cellular macromolecules that occurs over an organism's lifespan (Harman, 
1956). Ageing is inevitable and associated with a time-dependent decline in the 
biochemica l and physiolog ical function of major systems (Doria eta/. , 20 12). For 
example, an age-dependent increase in ROS was associated with functional decline or the 
mitochondria in rat brains ( Benzi et a/. , 1992). Moderate amounts of dietary antioxidants 
are like ly most beneficial late in Drosophila lifespan when intrinsic antioxidant defense 
no longer provide suffic ient protection against the age-dependent accumulation of ROS. 
My results are the first to demonstrate the effects of antioxidant supplementation 
at different time points during D. melanogaster development. The control used in this 
study closest to WT D. melanogasler was the responsive transgene-lacking ( IV1118) 
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control. As shown in Figures 8 and 14, pre-eclosion BBE supplementation did not affect 
the longevity or climbing ability of these tlies. Unfortunately, post-eclosion BBE 
supplementation experiments were not performed on this genotype; however, I can 
hypothesize that BBE extract would prolong lifespan based on my post-eclosion BB E 
supplementation results with LACZ tlies. Additionally, Peng eta/. have already 
documented that post-eclosion BB E supplementation extends lifespan in WT Drosophila 
(Peng et a/. , 20 12). Despite the detrimental effects observed in LACZ tlies, neither pre-
eclosion nor post-eclosion supplementation of BBE up to concentrations of 5 mg/ml 
appears to be harmful. My results support a role for BB E in promoting Drosophila 
longevity. 
Excessive disruption to biological pathiVays early in development may shorten lifespan in 
Drosophila 
I have found that tlies with targeted expression of lacZ in their DA neurons 
respond negati vely to BBE supplementation early in development. LACZ tlies exposed 
to BBE prior to eclosion had significantly reduced lifespans compared to individuals fed a 
control diet (Figure 8A & B). ROS present at appropriate amounts are regulators of 
severa l important cellular processes and it may be that the excess antioxidants provided 
by BBE are di srupting these pathways during development. For example, nitric oxide 
(NO) di rectly regulates gene expression and promotes ecdysteroidogenesis and 
metamorphosis during Drosophila development (Yamanaka and O'Connor, 20 11 ). 
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Excess antioxidants available during development could decrease the amount of ROS 
involved in signaling pathways below what is considered physiologically normal. This is 
not likely the case, however, as pre-eclosion supplementation of BBE was not found to be 
detrimental to responsive transgene-lacking control flies (Figure 8C & D). T hus, it 
appears that the combined presence of excess p-galactosidase and BBE supplementation 
early in development is likely responsible for shortening lifespan in LACZ tlies. 
As mentioned, lacZ is often used in Drosophila studies and its gene product, P-
galactosidase, is not associated with detrimental effects in fli es. Another possible 
scenario for LACZ/BBE supplementation toxicity involves the interaction between 
prote in accumulation and ROS. Despite p-ga lactosidase's benign nature in flies and its 
lack of substrate, I introduced a large quantity of exogenous and unnecessary protein into 
a sensitive D. melanogaster tissue. The ubiquitin proteasome system (UPS) is involved 
in maintaining cellular homeostasis via protein degradation. Degradation by the 
proteasome is signaled when at least four ubiquitin monomers are attached to an 
unwanted or unnecessary protein (Thrower eta/., 2000). The UPS is responsible for 
degrading up to 60% of unwanted or unnecessary proteins and is expected to be important 
to neuronal functioning and synaptic plasticity (Dennissen eta/. , 20 12). Thus, it is 
possible that the excess P-galactosidase present in DA neurons increases the acti vity of 
the UPS. Ubiquitin carboxyl-terminal hydrolase L I (UCH-L I) belongs to the famil y of 
deubiquitinating enzymes and is involved in regulating protein turnover via the UPS. The 
primary function of UCH-L I is to remove ubiquitin from protein substrates by 
hydrolysing carboxyl termina l esters and am ides of ubiquitin (Fang et a/. , 20 I 0). The 
methionine residues of this protein can be reversibly oxidized and this modi fica tion has 
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been suggested to be involved in regulating protein function (Hoshi and Heinemann, 
200 I). Excess antioxidant protection conferred by BBE supplementation may reduce 
ROS to a level below what is considered normal, thereby affecting the regulation of 
UCH-L I. Drosophila development prior to eclosion is a precisely coordinated and 
sensitive period involving many tightly regulated pathways. The combination of 
increased UPS activity alongside reduced regulation of the system may alter development 
in a manner that results in adults with decreased lifespans. This effect appears to be 
confined to occurring early in development since post-eclosion BB E supplementation did 
not harm LACZ flies (Figure I 0). Future studies should aim at evaluating differences in 
the expression and activity of enzymes like UCH-L I between LACZ fli es fed either a 
control or aBBE-supplemented medium. 
The a-svnuclein-induced premature loss of climbing ability was not reproduced in this 
study 
One of the characteristic features of the Drosophila a-syn model of PD is the 
premature loss of climbing ability. I was unable to reproduce this result and report that 
flies overexpressing a-sy n in their DA neurons do not lose thei r climbing ability earlier 
than control fli es. Several protocols ex ist for measuring locomotion (i.e. climbing ability) 
in Drosophila. A common method involves observing the movement of fli es through a 
clear vial or tube for a set amount of time. To obtain my results I used a graded analysis 
in which different zones were assessed a score that ascended with height. Previous 
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findings from our laboratory using the same protocol and the same Drosophi la o..-syn 
model of PD have reported a premature loss of climbing ability (Todd and Staveley, 
2008). Feany and Bender used a non-graded analysis and recorded how many fli es 
successfully passed a pre-determined height in a set period of time (Feany and Bender, 
2000). Both manual and automated methods were used by Wassef eta/. to measure 
locomotion in Drosophila (Wassef eta/. , 2007). Reactive locomotion was measured by 
vortexing tubes of flies at a low setting and measuring the number of fli es sti ll on the side 
of the tube. Spontaneous locomotion measurements were determined by computing how 
many times flies passed through an infrared laser over a set amount of time. Despite the 
varied protocols, both of the aforementioned groups reported a premature loss of climbing 
ability in Drosophila with increased neuronal expression of o..-syn. A consistent feature of 
these studies is the lack of a control I ine with directed expression of a non-detrimental 
protein in the same tissue. We used targeted expression of lacZ in D. melanogaster DA 
neurons to control for the effect of enhancing expression via the UAS/Ga/4 system. To 
my surprise, the progressive loss of climbing ability was similar in aSYN and LACZ fli es 
and neither differed from a responsive transgene- less control similar to those used by 
other groups (Figure II). Our graded method of measuring climbing ability is a sensiti ve 
and subjective assay that requires calculated and precise measurements of time and height 
over a long period of time. As such, it is possible that additional protocols may help to 
explain ambiguities between my results and those found by other groups. 
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A blueberry extract-supplemented diet only influences certain a-synuclein-induced 
phenotypes in D. rnelanogaster 
The severity of a-syn-induced phenotypes depends on both intrinsic and extrinsic 
factors. I have reported that D. melanogasler with targeted expression of a-syn in their 
DA neurons have a reduced lifespan (Figure 6 ). Unexpectedly, a signiticant difference 
was observed between aSYN/Ddc II and a SYN; Ode Ill flies with the former having a 
markedly reduced median surviva l time. Although both ofthe a forementioned aSYN 
lines model PO, it appears that the position o f Ddc-Gal4 in the D. melanogasler genome 
affects the severity of a-syn-induced phenotypes. Both lines of flies were maintained in 
the same condi tions and subjected to the same analyses with the only di fference between 
the two being the location of Ddc-Ga4. It is, there fore, possible that regulatory elements 
surrounding the chromosomal insertion site of Ddc-Gal4 affect its expression in D. 
melanogaster. Molecular analyses like qRT-PCR and Western blotting could be applied 
in future experiments to test for differential expression between a SYN/Ddc II and aS YN ; 
Ode Ill flies. Duplications and triplications of the a-syn gene locus resul t in a severe, 
early-onset version of PO in humans (S ingleton et a/. , 2003; C hartier-Harlin e/ a/. , 2004; 
Farrer e/ a/. , 2004). A similar expression-dependent effect may result from increased a-
syn transcript or prote in levels in D. melunugasler DA neurons. 
Temperature affects the amount of a -sy n-induced degeneration in Drosophila 
eyes. Directed expression of a-syn in D. melanogaster eyes at 25 oc produces subtle 
phenotypes. Conversely, flies raised at 29 oc have severely disrupted external eye 
morpho logies. In thi s case, the same genotype was ana lyzed and temperature a lone 
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appears to be responsible for the dramatic difference. The UAS/Ga/4 system used for 
targeted expression of a-syn in Drosophila eyes was isolated from yeast. The optimal 
temperature used to grow this microscopic eukaryote in most laboratories is 3 7 oc and 
this system functions better at temperatures approaching this point. Future experiments 
could not only analyze the amount of a-syn production at both 25 and 29 °C, but also the 
generation and binding capabili ty of Gal4 at these temperatures. 
A BBE-supplemented diet was only capable of suppressing the severe a-sy n-
induced phenotypes discussed above. Both the increased mortality and severe external 
eye disruption in aSYN flies were at least partially rescued by a BB E-supplemented diet. 
I have hypothesized that both genetic and environmental factors cause differential 
production of a-Syn in the lines that were tested. Recent studies have suggested that 
excess a-Syn increases oxidative stress by disrupting mitochondrial maintenance (Parihar 
eta/., 2009; Byers eta/. , 20 II). It is possible that secondary antioxidants obtained from 
food are only beneficial when a cell reaches a certain degree o f oxidative stress. A BBE-
supplemented diet was only beneficial when fed to aSYN flies pre-eclosion. Drosophila 
development is sens itive and precisely coordinated and the increased oxidative stress 
caused by excess neuronal a-Syn may di srupt this process. The increased antioxidant 
protection confetTed by BBE appears to protect against severe developmental damage 
caused by a-Syn-induced oxidative stress. 
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Possible mechanisms f or blueberry extract-induced protection in neurons 
My findings could be the result of a strengthened overall antiox idant defense 
system in a -sy n-expressing fli es. BBE extract increases the expression of intrinsic 
antioxidant defense enzymes like Cat, Sod/ , and Sod2 in Drosophila (Peng et a/. , 201 2). 
Additiona ll y, BB E extends lifespan and partially protects WT flies under conditions of 
increased ox idati ve stress; however, a similar e ffect was not found with e ither Cat or Sod 
knockout mutants. S imilar results have been documented for several other foods high in 
dietary antioxidants, including extracts of apple polyphenols, green tea catechins and 
black tea ( Li et a/. , 2007; Peng et a/. , 2009; Peng et a/. , 20 I I). A I though dietary 
antiox idants like ly provide an invaluable secondary support to cells undergoing oxidati ve 
stress it appears the ir protective e ffects are dependent on intrinsic enzymatic antiox idant 
defense systems. 
Directed expression of a-syn during eye development results in premature 
degeneration of the retina and abnormal development of the external eye morphology 
(Haywood and Staveley, 2004; Todd and Staveley, 2008). My resul ts suggest that a d iet 
conta ining BBE protects neurons in the eye against severe a -sy n-dependent de fects. Both 
the amount o f atypica l ommatidia and total number of bri stles were improved in tlies fed 
a BB E-supplemented diet. A lthough the protective mechani sm is not understood, a link 
exists between BB E supplementation and protein turnover via the UPS. Flies fed BB E 
have increased levels of Rpn/1 messenger RN A (Peng et a/. , 201 2), an essentia l lid 
component of the 26S proteasome structure. In humans, the parkin gene (PA RK2) 
encodes a 465 aa protein that functions as an E3 ubiquitin ligase (Shimura et a/. , 2000). 
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Expression of parkin in Drosophila eyes suppresses a-syn-induced retina l degeneration in 
older fli es (Haywood and Staveley, 2004). Additionally, overexpression of endoplasmic 
reticulum-associated degradation pathway prote ins suppress late onset retinal degradation 
in a Drosophila model of autosomal dominant retini tis pigmentosa, an age-related 
degenerative eye di sease (Kang and Ryoo, 2009). The authors hypothesized that thi s 
restoration is due to increased proteasomal degradation of mis folded proteins in the 
endoplasmic reticulum. Post-mortem ana lysis of PD patient bra ins reveals that ubiquitin 
is a major component o f LBs and LNs present in surviving DA neurons ( Bancher et a/. , 
I 989) and protein aggregation/ turnover is of particular interest in research pertaining to 
PD etio logy. The neuroprotective effects of BB E on a-syn-induced damage in the D. 
melanogaster eye may be due in part to increased activity of the UPS system. 
CONCLUSION 
Recent evidence suggests that a diet ri ch in blueberries may he lp slow the age-
related degeneration of neurons. In a human study, blueben-y j uice supplementation 
improved memory function in older adults w ith early memory decli ne (Kri korian eta/. , 
20 I 0). Other groups have demonstrated that short-term blueberry supplementation both 
increased HSP70-mediated protection against inflammation in aged hippocampal cells 
and improved object recognition memory in older rats (Goyarzu eta/., 2004; Gall i eta/., 
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2006). These studies suggest that the neuroprotective effects of blueberries or BBE are 
not confined to D. melanogaster and may extend to mammals. 
I have hypothesized that increased protein turnover and intrinsic antioxidant 
protection result from BBE supplementation in D. melanogaster. a-Syn appears to 
influence mitochondrial maintenance and its toxicity in cells depends on protein 
conformation. lfBBE supplementation does indeed increase UPS and antioxidant 
activity simultaneously, this would provide cells with a two-tiered protection system for 
e liminating both misfolded protein and excess ROS generated from mitochondrial 
dysfunction. If these results extend to humans, dietary antioxidants could potentially be 
used as a safe and natural component of future PO treatment plans. 
Here, I present the first demonstration of the neuroprotective effects of an extract 
of blueberries in a Drosophila mode l of an a-Synucleinpathic disease. Previous findings 
have demonstrated that grape extract improved both the early mortality and premature 
decline in locomotion in a similar Drosophila model of PO (Long eta/. , 2009). 
Additionally, grape seed extract restored external eye morphology and increased lifespan 
in Drosophila mode ls oftaupathy and Huntington disease, respectively (Pfleger et a/., 
20 I 0; Wang eta/. , 20 I 0). Taken together, these results demonstrate the value of using 
Drosophila to study neurodegenerati ve disorders. Though the literature is relati vely new, 
studies in this versatile organism have he lped develop interest in the potentia l 
neuroprotective effects of dietary antioxidants in medical research. Future studies should 
aim towards unrave ling the interaction of dietary antioxidants and the activity of cellular 
mechanisms, such as the UPS and enzymatic antioxidant pathways. 
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APPENDIX 1 
The following is a copy of a manuscript that was prepared for publication using the 
results of this study: 
Blueberry extract supplemented diet improves a-synuclein-induced phenotypes in a 
Drosophila melanogaster model of Parkinson disease 
ABSTRACT 
Oxidative stress is consistently associated with Parkinson disease (PO) etiology. 
We investigated the effects of blueberry extract (BBE) supplementation on a-synuclein 
induced phenotypes in a Drosophila melanogas/er model of PD. Enhanced a-::,ynuclein 
expression in Drosophila dopaminerg ic (DA) neurons reduces li fespan. We performed 
longevity assays to measure the effects of BBE on Drosophila lifespan. Flies expressing 
a-synuclein in their DA neurons fed BBE had a 9% longer median li fespan than those fed 
a contro l diet. BBE also improved a-synuclein-induced developmental defects in the 
Drosophila eye. Our biometric analyses revealed that individuals fed BB E had less 
atypica l ommatidia as well as an increased number of mechanosensory bristle cells than 
those fed a control diet. We propose that BBE, rich in naturally occurring antioxidants, 
promotes the survi val of neurons in tissues with increased levels of a-Synuclein through a 
protective mechanism involving other cell s igna ling pathways. 
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INTRODUCTION 
Parkinson disease (PO) is the second most common progressive 
neurodegenerative disorder behind Alzheimer's disease (de Moura et al., 20 I 0). The 
pathophysiological ha llmarks of PO include the loss of dopaminergic (OA) neurons in the 
substantia nigra pars compacta (SNc) and the presence of intraneuronal inc lusions known 
as Lewy bodies (LB) in surviving cells. Affected individuals have both motor and non-
motor symptoms rang ing from bradykinesia, resting tremor, and muscular rig idity to 
dementia, depression and olfactory dysfunction. Initially be lieved to be an entirely 
sporadic disease, linkage studies identified a-synuclein (PARK 1/4) as the first gene 
related to PO (Polymeropoulos eta/. , 1997). The human a-synuclein gene (SNCA) 
encodes a 140 aa peripheral membrane prote in that localizes to the pre-synaptic region of 
neurons (Stefan is, 20 12). Both point mutations and duplications of its gene locus result in 
autosomal-dominant PO (AOPO), the latter causing a more severe early-onset form of the 
disease. Additionally, both LBs and Lewy neurites, located in the perikarya and neuronal 
processes, respectively, stain positive ly for a-Synuclein. a-synuclein is associated with 
both sporadic and familial PO and seems to play a critical role in its etiology. 
Oxidati ve stress is consistently associated w ith the pathogenesis of PO however 
its role in di sease progression remains unclear. A cell undergoes oxidative stress when 
the net balance between the generated reactive oxygen species (ROS) and the ava ilable 
antiox idant defense mechanisms favours the former. Post-mortem ana lysis of PO patient 
brains reveals higher levels of oxidative stress biomarkers like dys functiona l 
mitochondria, decreased levels of reduced gluta thione, and de ficiencies in antioxidant 
enzymes in the SN of a ffected individuals (Schapira and Jenner, 20 I I). Recent evidence 
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suggests pluripotent stem cell-derived DA neurons from a PO patient w ith a SNCA 
triplication accumulate a-synuclein and are susceptible to oxidative stress (Byers et at. , 
20 II ). This data suggests that the combination of oxidative stress and excess a-Synucle in 
may play a pivotal role in the progression of PD. 
The toxicity of excess a -Synuclein appears to be enhanced under conditions o f 
oxidati ve stress. Studies in Drosophila melanogaster have been especia lly helpful in 
e lucidating this relationship. Neural expression of a-sy nuclein in Drosophila brains and 
DA neurons recapitulates the locomotor dys functions, age-dependent degeneration o f DA 
neurons, and formation of LBs characteri stic of human PO (Feany and Bender, 2000). 
Decreased lifespan and retinal degeneration have also been observed in Drosophila w ith 
increased neuronal levels of a-Synuclein (Wassef et a/. , 2007). Co-expression o f 
methionine su(foxide reductase A (MSRA) and ?TEN-induced putative kinase I (PINK/), 
involved in ROS neutralization and damaged mitochondrion turnover, respectively, with 
a-synuclein improves PD-related phenotypes (Todd and Stave ley, 2008). G iven their 
versatility, Drosophila can help unravel the role of oxidative stress in PO and unveil any 
potentia l antioxidant therapies. 
Blueberries are an exce llent source of dietary antioxidants. The therapeutic 
potential of blueberries in cancer and vascular disease has been described and recent 
studies in Drosophila suggest that plant extracts may be bene fi cial to individuals suffering 
from neurodegenerati ve diseases (Neto, 2007; Long et a/. , 2009). In this study we 
describe the restorative effects of Webber Naturals' 36: I concentrate blueberry extract 
(BB E) on a Drosophila model of PD. Enhanced morta lity and eye degeneration caused 
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by directed expression of a-synuclein in the DA neurons and developing eye, 
respectively, is improved by supplementing growth media with BBE. 
MATERIALS AND METHODS 
Fly stocks and culture 
The UAS-a-synuclein (Feany and Bender, 2000) and Ddc-Gal4 (Li eta/., 2000) 
fli es were generously provided by Dr. M. Feany (Harvard Medical School) and Dr. .1. 
Hirsh (U ni versity of Virginia), respectively. GMR-Gal4 (Freeman, 1996) and UAS-IacZ 
(Brand and Perrimon, 1993) flies were obtained from the Bloomington Drosophila Stock 
Center at Indiana University. Directed expression of the transgenes in DA neurons and 
during early eye development was accomplished by crossing homozygous Ddc-Gal4 and 
GMR-Gal4 females, respectively, to homozygous UAS-a-synuclein (PD model) and UAS-
IacZ (control) ma les as per standard methods. Flies were fed either a standard cornmeal-
yeast-molasses-agar medium (65 g/L cornmeal, 15 g/L nutritional yeast extract, 5.5 g/L 
agar, 50 milL fancy grade molasses in water supplemented with 0. 1 g/ml methy l paraben 
in ethanol and 2.5 ml proprionic acid) or standard medium supplemented with either I 
mg/ml or 5 mg/ml Webber Naturals' 36: I concentrate BBE (WN Pharmaceuticals0il Ltd. , 
Coquitlam, B.C., V3K 7B5, w1vw. webbernaturals.com) 
Longevity assay 
Flies were collected under gaseous C02 every 24 hours until a mini mum of200 
adult males of each genotype were obta ined. They were then transferred to upright 
standard plastic she ll vials containing standard (control), or standard medium 
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supplemented with either I mg/ml or 5 mg/ml BBE. Each group was maintained at 25 oc 
and kept in non-crowded conditions ( 1-20 individuals per vial). Flies were scored for 
viability every 2 days and transferred to fresh medium without anesthesia according to 
established protocol (Staveley et al., 1990). Survival fractions were calculated in Prism 
version 5.0b for Mac OS X (GraphPad Software, San Diego California USA, 
www.graphpad.com) using the product limit (Kaplan-Meier) method. 
Scanning electron microscopy and biometric analyses 
Flies were reared and aged 3 to 5 days post-eclosion on either standard or BBE 
supplemented medium at 29 oc. Surviving flies were preserved at -80 oc before being 
mounted on metal studs under a dissecting microscope. Prepared flies were desiccated 
overnight and gold coated prior to photography at 170 times magnification with a Hitachi 
S-570 scanning electron microscope as per standard methods. 
All biometric analyses were measured using lmageJ64 version 1.42q (Abramoff et 
al. , 2004). The area of a single ommatidium was determined by dividing the average area 
of a floret of ommatidia by 7 (data not shown). These numbers were used to di stinguish 
between normal and atypical ommatidia when measuring percent di sruption. A disrupted 
or atypical ommatidium had an area 50% smaller or 150% larger than a typical 
ommatidium for that condition. An oval with an area between 35000-40000 ~Lm2 was 
overlaid on the flattest portion of each analyzed eye with Paintbrush version 2.1.1 for 
Mac OS X (Copyright © 2007-20 I 0 Soggy Waffles). Individual disrupted areas within 
the oval were measured in triplicate and a percent value was obtained by di viding the 
summed average values into the average area of the oval (also measured in triplicate). n 
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= 15 for each analyzed condition for both bristle counts and ommatidium area 
measurements, whereas n = I 0 for percent disruption analysis. Bar graphs were produced 
using Pri sm version 5.0b for Mac OS X (GraphPad Software, San Diego Cal ifornia USA, 
1Vw1v.graphpad. com). 
RESULTS 
Increased concentrations of blueberry extract protects against a-Synuclein-induced earfv 
mortalitv 
Here we report a reduced lifespan in fli es when a-synuclein expression is 
enhanced in the DA neurons (Figure I A). The median survival time o f a-synuclein-
expressing flies was reduced by 37% compared to the lacZ cohort when both groups were 
fed a contro l diet. A diet rich in BB E partially rescued the reduced lifespan caused by 
increased neuronal amounts o f a-Synuclein in Drosophila (Figure I B). a-synuclein fli es 
fed a d iet containing 5 mg/ml BB E had a 9% longer median lifespan than those fed a 
contro l diet, whereas a similar result was not found with a concentration of I mg/ml BB E. 
The median survival values for each group are found in Table I. 
Blueberry extract suppresses a-Synuclein-induced degeneration in the developing ~ve 
A rough external eye phenotype occurs when GMR-Gal4 is used to drive 
expression of a-synuc/ein in the developing Drosophila eye (Figure 2B)(Todd and 
Staveley, 2008). BBE supplementation restores mean a-.sy nuc/ein-induced disruption 
back to control levels (Figure 2E). The mean disruption of lacZ fli es fed a control diet 
was 29% of the analyzed area. In a-synuc/ein fli es, the mean di sruption was reduced 
88 
from 73% in those fed a control diet to 40% and 29% in flies fed I and 5 mg/ml BB E, 
respectively. Increased a-Synuclein levels reduced the mean number of bristles per eye 
to 373 in fli es fed a control diet, whereas lacZ fli es on the same diet had 541 (Figure 2E). 
The number of bristles per eye was raised to 415 and 438 when the a-synuclein flies were 
fed a diet cons isting of I and 5 mg/ml BBE, respectively. Th is provides another example 
of BBE-induced protection against PD-related cell death in a Drosophila tissue that is rich 
111 neurons. 
DISCUSSION 
Recent evidence has suggested that a diet rich in blueben·ies may help slow the 
age-related degeneration of neurons. In a human study, blueberry juice supplementation 
improved memory function in older adults with early memory decline (Krikorian eta!., 
20 I 0). Furthermore, Galli et a!. have demonstrated that short-term blueberry 
supplementation increased heat shock protein 70 (HS P70)-mediated protection against 
inflammation in aged rat hippocampal cells (Galli eta!., 2006). These studies suggest 
that the neuroprotective effects of blueberries or BBE are not confined to Drosophila and 
may translate to mammals. 
The Free Radica l/Oxidative Stress theory of ageing orig inated in the 1950's and 
suggests that an organism ages due in part to the accumulation of free radical-induced 
damage to its cellular macromolecules. Previous studies have shown that BBE is capable 
of extending lifespan Drosophila rnelanogaster (Peng et a!., 20 12). O ur results are novel 
as we have shown that BBE supplementation can extend lifespan in a Drosophila model 
of a neurodegenerative disease. T he additional antiox idants provided by BB E 
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supplementation may alleviate some o f the excess ROS generated during the progression 
of PO-l ike cell death resulting in less cellular damage and a longer median survival time 
in affected fl ies. 
The Drosophila compound eye consists of multiple subuni ts, or ommatid ia, 
composed o f several neurons and peripheral mechanosensory bristle cells. Directed 
expression of a-synuclein during early eye development resul ts in premature degeneration 
of the retina and the abnormal development of the external morphology o f the eye 
(Haywood and Staveley, 2004; Todd and Staveley, 2008). Our resul ts suggest that a diet 
conta ining BBE protects neurons in the eye against a -synuc/ein-dependent de fects. Both 
the amount of atypical ommatidia and total number of bristles were improved in tlies fed 
a BB E-supplemented diet. A link exists between BBE supplementation and protein 
turnover via the ubiquitin proteasome system (UPS) as flies fed BBE have increased 
levels of Rpn II messenger RNA, an essential lid component of the 26S proteasome 
structure (Peng et a/. , 201 2). In humans, the parkin gene (PARK2) encodes an E3 
ubiquitin ligase and expression of parkin in Drosophila eyes suppresses a-svnuclein-
induced retinal degeneration in older tlies (Haywood and Staveley, 2004). Protein 
aggregation/tumover is a point of major interest in PO etio logy and the neuroprotective 
effects of BBE on a-synuclein-induced damage in the Drosophila eye may be due in part 
to increased activity of the UPS system. 
Our findings could be the result of a strengthened overall antiox idant de fense 
mechani sm in a-.synuc/ein-expressing tlies. BB E extract increases the expression of 
intrinsic antioxidant defense enzymes I ike catalase (Cat), Sod I, and Mn superoxide 
disnwtase (Sod2) in Drosophila (Peng et a/., 20 12). Additionally, BB E extends li fespan 
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and partially protects flies under conditions of increased oxidative stress, however no 
effect was seen with either Cat or Sod knockout mutants. Similar results have been 
documented for several other foods high in dietary antioxidants, including extracts of 
apple polyphenols, green tea catechins and black tea (Li eta/., 2007; Peng eta/., 2009; 
Peng eta/. , 20 II). Although dietary antioxidants likely provide an invaluable secondary 
support to cells undergoing oxidative stress it appears their protective effects are 
dependent on intrinsic enzymatic antioxidant defense systems. 
Here we present the first demonstration of the neuroprotective effects of BBE in a 
Drosophila model of a-Synucleinpathic di sease. Previous findings by Long el a/. 
demonstrated that grape extract improved both the early mortality and premature decline 
in locomotion in a similar Drosophila model of PO (Long et al., 2009). Taken together, 
these results epitomize the value of using Drosophila to study PO etiology. Though the 
literature is relatively new, studies in this versatile organism have helped develop interest 
in the potential neuroprotective effects of dietary antioxidants in medical research. Future 
studies could aim towards unraveling the interaction of dietary antioxidants and the 
activity of cellular mechanisms, such as the UPS and enzymatic antioxidant pathways. 
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TABLES 
Table I - Median surv ival times of Drosophila melanogaster reared on either a standard 
or blueberry extract (BBE)-supplemented diet 
Genotype (food medium) Median survival (days) 
1118 S I I G w : UA - acZ Ddc- al4 (control) 8t' 
'''8 S I d G w : UA -o..-syn D c- al4 (control) 
'''8 S I w : UA -o..-syn Ddc-Gal4 ( I mg/ml BBE) 
,,,8 S I 1v : UA -o..-syn Ddc-Gal4 (5 mg/ml BBE) 
Groups w ith different superscripted letters were deemed s igni licantly diffe rent (p < 0.05) by the log-rank 
(Mantel-Cox) test followed by a Bonferroni multiple comparison correction 
FIGURE LEGENDS 
Figure I - Blueberry extract (BBE) partially protects Drosophila melanogaster 
against o..-synuclein-induced early mortality. A Directed expression of o..-synuclein (n 
= 2 18) in DA neurons shortens lifespan in Drosophila fed a standard diet, as compared to 
a lacZ (n = 227) control (p < 0.05). B Flies feel diets containing 5 mg/ml BBE (n = 283) 
were partially protected against the a -synuclein-incluced mortality (p < 0.05), whereas I 
mg/ml BBE (n = 267) had no significant effect. Genotypes are w1118: UAS-IacZ/Ddc-
Gal4 (control) and w1118 ; UAS-o..-sy nuclein/Ddc-Gal4 (aSYN). Errors bars represent 
standard error of the mean. p-values were calculated by the log-rank (Mantel-Cox) test 
and multiple comparisons were corrected for using the Bonferroni method. 
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Figure 2- Blueberry extract (BBE) supplementation counteracts a-synudein-
induced developmental defects of the eye. A-D Scanning electron micrographs of 
adult eyes. B Overexpression of rx-.\ynuclein during early eye development produces a 
rough external eye morphology. X denotes mg/ml. E Flies suppl emented w ith BBE 
have disruption levels comparable to the lacZ control (* represents p 0 .05). F BBE 
supplementation increases mean bri stle number and partia lly rescues the rx-.\~1"111/c/ein-
induced decrease(* represents p < 0.05). Genotypes are v. ./ 118: UAS-IacZIC MR-Ca/4 
(contro l) and w1118: UAS-rx-synuc/ein/CMR-Ca/4 (aSY ). Error bars represent standard 
e1Tor of the mean. p-va lues were calcu lated via one-way A OVA fo llowed by Tukey's 
Multiple Comparison test. 
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Figure 1 - Blueberry extract (BBE) partially protects Drmwphila melanogaster 
against a-.\ynuclein-induced early mortality 
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induced developmental defects of the eye 
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APPENDIX 2 
Possible explanation for the lifespan variability in a-synuclein- and lacZ-
expressing D. melanogaster fed control medium observed from two independent 
experiments 
Two separate experiments were performed when analyzing the effects of exposing 
D. melanogasler to a SSE-supplemented diet. The lifespans of flies fed a standard 
(control) medium di ffered greatly between the pre- and post-eclosion supplementation 
experiments as can be seen in Table A2.1. The genotypes tested in the two experiments 
were identical and crosses were executed with the same procedures and equipment. The 
only difference between the two experiments was the location in which the flies were 
maintained during testing. The pre-eclosion longevity assays were performed in our 
laboratory in the basement of the Biotechnology building, whereas the post-eclosion 
experiments were conducted in an equipment storage room on the first floor of the 
Science building due to space constraints in the laboratory incubator. The median 
surviva l times reported from the latter experiment are significantly shorter than those 
discovered during the pre-eclosion assays. This difference is likely due to an unknown 
environmental factor as the food media and tly lines used were the same in each 
experiment. The incubator in which the flies were maintained during the post-eclosion 
experi ment was checked regularly for temperature changes, however, the incubator was 
an older piece of equipment and any fluctuations outside of work hours might have gone 
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unnoticed. The variability reported between the pre- and post-eclosion supplementation 
experiments is unfortunate, however it does not change the results I have reported for the 
effects o f BBE supplementation on a -syn-induced phenotypes. 
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Table A2. 1 - Median survival times of o.-synuclein- and /acZ-expressing D. melanogaster 
fed control media from two independent experiments 
Genot e 
w
1118
; UAS-o.-syn/Ddc-Ga/4 ( I) 
1//8 s 1 w ; UA -o.-sy ntDdc-Ga/4 (2) 
w
11 18
: UAS-o.-synl+; Ddc-Ga/4/+ ( I ) 
w
11 18
; UAS-o.-sy nl+: Ddc-Ga/4/+ (2) 
w
1118
: UAS-/acZ/Ddc-Ga/4 (I) 
w
1118
; UAS-/acZ/Ddc-Ga/4 (2) 
1v
1118
: UAS-IacZI+: Ddc-Ga/4/+ ( I ) 
w
1118
: UAS-/acZI+; Ddc-Ga/4/+ (2) 
Median survival (da s) 
46" 
si' 
si' 
Different superscripted letters indicate a significant difference (p < 0.05) between values for a particu lar 
genotype; comparisons were not made between different genotypes 
I: post-eclosion supplementation experiment, 2: pre-eclosion supplementation experi ment 
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